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This thesis examines and addresses the challenges faced in the 
development of protein-specific probes by integration of various emerging 
interdisciplinary and enabling platforms. 
 
The first part of the thesis presents the selection of aptamers for different 
signal transduction proteins, i.e. Cell division cycle 42 (Cdc42), p21-
activated kinase (PAK) and Myotonic dystrophy kinase-related Cdc42-
binding kinase (MRCK), which was achieved through the optimization of 
non-SELEX conditions, including sample injection volume, run buffer and 
incubation buffer. The analysis of PCR products for the optimization of 
PCR conditions was also done to ensure high purity of enriched libraries 
obtained through the aptamer selection process. Subsequently, binding 
parameters of the respective aptamers obtained for each protein was 
determined using Non-Equilibrium Capillary Electrophoresis of Equilibrium 
Mixtures (NECEEM) to identify the best binders.  
 
The second part of the thesis describes the modification of a 
representative MRCK aptamer into a hairpin structure for the development 
of aptamer probes. Solution studies on the selectivity of the aptamer probe 
were carried out to check the target specificity of the modified aptamer. 
Preliminary experiments were also done using the MRCK aptamer to 




Lastly, this thesis concludes the research findings with a discussion on the 
challenges that arose and suggestions to overcome these problems were 
provided for consideration for future development of aptamer probes. 
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Chapter 1 Introduction 
1.1 Selection of aptamers 
1.1.1 Systematic Evolution of Ligands by EXponential enrichment 
(SELEX) 
Aptamers are single-stranded (ss) DNA or RNA oligonucleotides that can 
bind with high affinity and specificity to a wide range of target molecules, 
such as small molecules and proteins [1-3]. They are screened from a 
randomly generated population of ssDNA/RNA sequences for their ability 
to bind with desired molecular targets in a general approach termed 
SELEX [4-7], which was first reported in 1990. The screening process of 
SELEX mimics natural selection as shown in Figure 1.1. 
 
Figure 1.1 Generation of aptamers using the traditional SELEX 
 
ssDNA / RNA pool
Target 
Incubation of 




Elution of ssDNA / 





(10 – 15 times) 
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A random nucleic acid library with sequences from 22 - 100 nucleotides in 
length gives rise to an enormous diversity of possible sequences that 
generates a vast array of different conformations with different binding 
properties. Selections were initially carried out with RNA pools due to the 
known ability of RNAs to fold into complex structures which can be a 
source of diversity of RNA function. More recently, ssDNA pools have also 
been used to yield aptamers [8, 9] as they are less susceptible to 
hydrolysis as compared to RNA and are also known to fold in vitro into 
structures containing stem-loop, internal loops, etc [10].  
 
The SELEX cycle starts with the incubation of the library with the target 
molecule under conditions favorable for binding, followed by partitioning 
unbound nucleic acids from those bound specifically to the target molecule. 
Next, the nucleic acid-protein complexes are dissociated to enable 
amplification of the nucleic acids for pool enrichment. These steps are 
reiterated based on the type of library used as well as by the specific 
enrichment achieved per selection cycle, before subjecting the resulting 
oligonucleotides to DNA sequencing. The sequences are then screened 
for conserved regions and structural elements indicative of potential 
binding sites and subsequently tested for their binding specificity to the 
target molecule. Along with the large number of possible oligonucleotide 
sequences and molecular diversity, it is theoretically possible to obtain 
aptamers that can recognize virtually any target molecules with a very 
Chapter 1 Introduction 
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high affinity [11]. Dissociation constants obtained are typically from the 
micromolar to low picomolar range, comparable to those of some 
monoclonal antibodies, sometimes even better [12]. This is due to their 
capability to fold upon binding their target molecule; by incorporating small 
molecules into their nucleic acid structure or integrating into the structure 
of larger molecules such as proteins [13]. 
 
Aptamers have the potential to change the field of affinity probes and 
replace antibodies as diagnostic, analytical [14, 15] and therapeutic 
reagents [16, 17]. The ease and low cost of production; and the simplicity 
of chemical modifications and integration into different analytical schemes 
are clear advantages aptamers have over traditional antibodies. The main 
advantage is overcoming the use of animals for antibodies production by 
inducing an immune response to the target analyte. However, the immune 
response can fail when the target protein has a structure similar to 
endogenous proteins and when the antigen consists of toxic compounds. 
Furthermore, the animal immune system selects the sites on the target 
protein to which the antibodies bind, thus restricting the identification of 
antibodies that can recognize targets only under physiological conditions. 
This limits the extension to which the antibodies can be functionalised and 
applied; unlike the aptamer selection process that can be manipulated to 
obtain aptamers that bind a specific region of the target and with specific 
binding properties in different binding conditions. Aptamers are also 
Chapter 1 Introduction 
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produced by chemical synthesis and purified to a very high degree by 
eliminating the batch-to-batch variation found when using antibodies. 
Through chemical synthesis, modifications in the aptamer can be 
introduced; enhancing the stability, affinity and specificity of the molecules, 
thus imparting greater resistance to denaturation and a much longer shelf 
life [2, 16, 18, 19]. 
 
Despite the vast potential and significant effort in the development of 
aptamers over the past 20 years, the progress has been slow largely due 
to the limitations of conventional technologies used for aptamer 
development [20]. Traditional SELEX procedure typically takes up to three 
months. A recently published in silico method for RNA aptamer selection 
also requires the same duration [21]. A new technique employing capillary 
electrophoresis as an instrumental platform for SELEX known as CE-
SELEX was developed by Mendonsa and Bowser [22] to increase the 
efficiency of the current SELEX technology as well as suggest the 
possibility of automation. Krylov et al. further improved the protocol and 
eliminated potential problems during the amplification step by introducing 
a modified CE-SELEX method termed non-SELEX [20].  
 
1.1.2 Capillary Electrophoresis as a tool for SELEX (CE-SELEX) 
Whereas the basic methodologies for in vitro selection have been proven 
robust for the identification of high affinity aptamers against a variety of 
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important targets, continued improvements in selection technology should 
abet the generation of aptamers with even higher affinities and greater 
efficiency [23]. Traditional methods of partitioning, such as filtration and 
gel-electrophoresis, were initially used for SELEX. Because of high 
background (the high level of target-non-bound DNA collected along with 
target-bound DNA), SELEX based on conventional partitioning methods 
requires a large number of selection rounds, typically greater than 10, 
which is time- and resource-consuming. It often leads to DNA structures 
that bind to the surfaces of the filters or chromatographic support used 
rather than to the target. Another disadvantage of too many rounds of 
selection is the very limited number of unique aptamer sequences 
obtained at their output. Finally, if the efficiency of partitioning is too low, 
SELEX can completely fail to select aptamers.  
 
In particular, it is possible to select aptamers with extremely well-defined 
affinity profiles using capillary electrophoresis (CE). Bowser and 
Mendonsa were the first to develop a new technique called CE-SELEX, 
which uses Non-Equilibrium Capillary Electrophoresis of Equilibrium 
Mixtures (NECEEM) in SELEX. This approach utilizes electrophoresis to 
separate binding sequences from inactive ones. Selection occurs in free 
solution with CE-SELEX, eliminating stationary support and linker biases. 
Active sequences that bind the target undergo a mobility shift, and thus 
can be separated from inactive sequences and collected as separate CE 
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fractions. Hence, there is no need to perform a washing step as in 
conventional SELEX, eliminating kinetic bias. The partitioning efficiency of 
CE-SELEX also exceeds that of conventional partitioning methods, by at 
least two orders of magnitude, which decreases the number of rounds of 
SELEX from ≥ 10 to 1–3. In addition, NECEEM has been demonstrated to 
facilitate the selection of ‘smart’ aptamers - ligands with predefined binding 
parameters [20, 24]. 
 
Aptamers for protein targets that have been selected using CE-SELEX 
include protein kinase C [25], human IgE [26, 27], neuropeptide Y [28],  
HIV-1 reverse transcriptase [29], MutS [30, 31], and protein 
farnesyltransferase [32]. Recently, Krylov et al. selected aptamers using h-
Ras as the protein target, based on a modified process from CE-SELEX 
known as non-SELEX [33], which involves repetitive steps of partitioning 
with no amplification between them. This increases speed and simplicity, 
while avoiding quantitative errors associated with the exponential nature of 
PCR amplification and biasness related to differences in PCR efficiency 
with respect to different oligonucleotide sequences [33]. Hence, non-
SELEX can potentially provide a viable alternative to SELEX in the 
commercial development of aptamers [20]. 
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1.1.3 Basic principles of capillary electrophoresis 
Capillary electrophoresis encompasses a family of related separation 
techniques that use narrow-bore fused-silica capillaries to separate a 
complex array of large and small molecules. For the purpose of this work, 
the simplest form of CE, Capillary Zone Electrophoresis (CZE) was 
employed. Introduced in the 1960s by Hjerten et al. [34], the separation 
mechanism is based on differences in the charge-to-mass ratio of the 
analytes. Fundamental to this technique are homogeneity of the buffer 
solution and constant field strength throughout the length of the capillary. 
Separation relies principally on the pH controlled dissociation of acidic 
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A basic schematic of a CE system is shown in Figure 1.2. The inlet vial, 
outlet vial and capillary are filled with an electrolyte such as an aqueous 
buffer solution. The sample is introduced into the capillary via pressure, 
and then an electric field is supplied to the electrodes by high-voltage 
power supply across the capillary to pull all ions, positive or negative 
through the capillary in the same direction by electroosmotic flow. The 
analytes separate as they migrate based on their electrophoretic mobilities, 
which are detected near the outlet end of the capillary. The output of the 
detector is sent to a computer with data acquisition software, which 
displays separated chemical compounds resulting from different charge-




The most common detection system employed for CE uses UV 
absorbance. For on-line detection, a small section of the capillary is burnt 
to remove the polyimide coating so that it is optically transparent for its 
use as a detection cell, which enables detection of separated analytes 
with no loss of resolution. The path length of the detection cell (~ 50 µm) is 
far less than that of a traditional UV cell (~ 1 cm), thus resulting in reduced 
sensitivity according to the Beer-Lambert law.  
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Alternative detection mode in CE systems which offers high sensitivity is 
laser-induced fluorescence (LIF) detection that is known to have detection 
limits as low as picomolar due to the high intensity of the incident light and 
the ability to accurately focus the light on the capillary. However, it is only 
suitable for samples that naturally fluoresce or are chemically modified to 
contain fluorescent tags.  
 
1.1.3.3 Modes of separation 
The separation of compounds by CE is dependent on combined effects of 
the electroosmotic force (EOF) and the inherent electrophoretic mobility of 
the analytes. The effective electrophoretic mobility (µeff) of an analyte 
toward the electrode of opposite charge is as shown in Equation 1.1. 
Equation 1.1:   µeff = µep  + µEOF  
 
where µep is the electrophoretic mobility of the analyte and µEOF is the 
electroosmotic mobility of the buffer. µep of an analyte at a given pH is 
given by Equation 1.2, which indicates that it is proportional to the ionic 
charge of a species and inversely proportional to any frictional forces 
experienced by the analyte ion, which depends on the viscosity (η) of the 
medium and the size and shape of the ion.  
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Equation 1.2:   
r
z
ep πηµ 6=  
where z is the net charge of the analyte and r is the Stokes radius of the 
analyte.  
In a fused-silica capillary, silanol (Si-OH) groups attached to the inner 
surface of the capillary are ionized to negatively charged silanoate (Si-O-) 
groups at pH values greater than three. A basic solution such as NaOH is 
usually rinsed through the capillary to enhance the ionization of the 
capillary wall prior to introducing the buffer solution. The positively 
charged cations of the buffer solution will be attracted to the negatively 
charged silanoate groups, forming two inner layers of cations – fixed and 
mobile layer (called the diffuse double layer or the electrical double layer) 
as shown in Figure 1.3. For normal polarity, the mobile cation layer is 
pulled in the direction of the negatively charged cathode when an electric 
field is applied, dragging the bulk buffer solution along as these cations 
are solvated, resulting in the EOF of the buffer solution. The rate of EOF 
as shown in Equation 1.3 is dependent on the field strength and the 
charge density of the capillary wall, which is proportional to the pH of the 
buffer solution. The EOF is also dependent on several other factors such 
as ionic strength and viscosity of background electrolytes.  
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Figure 1.3 Diagram of the separation of charged and neutral analytes (A) 
according to their respective electrophoretic and electroosmotic flow 
mobilites; and illustration of the diffuse double layer on the capillary wall. 
 




where ζ is the zeta potential of the capillary wall, and ε is the relative 
permittivity of the buffer solution.  
Since the EOF of the buffer solution is generally greater than that of the 
electrophoretic flow of the analytes, all analytes are carried along with the 
buffer solution toward the cathode. The overall order of migration seen by 
the detector is shown in Figure 1.3. Positively charged analytes are 
attracted to the cathode, while negatively charged analytes are attracted 
to the positively charged anode, thus retain longer in the capillary due to 
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1.1.4 Non-Equilibrium Capillary Electrophoresis of Equilibrium 
Mixtures (NECEEM) 
CE has been the technique of choice for studies of biomolecular 
interactions through homogenous free-solution separation. Krylov et al. 
has introduced the term kinetic capillary electrophoresis (KCE) [36] for 
various methods, including non-equilibrium capillary electrophoresis of 
equilibrium mixtures (NECEEM) [37-39], equilibrium capillary 
electrophoresis of equilibrium mixtures (ECEEM) [30], plug-plug kinetic 
capillary electrophoresis (ppKCE) [40], and sweepCE.  Being a 
homogenous kinetic approach, KCE allows accurate determination of 
equilibrium and kinetic parameters of biomolecular interactions [31]. 
Among all the KCE methods, NECEEM technique is applicable to the 
selection of aptamers with different dissociation rate constants.  
 
The concept of NECEEM-based selection of aptamers is depicted in 
Figure 1.4. In the first step, a naïve DNA library (every sequence is 
statistically unique) is mixed with the target protein (P) and incubated to 
form the equilibrium mixture (EM). DNA molecules with high affinity 
(potential aptamers) bind P, while those with low affinity (non-aptamers) 
do not bind. As a result, the EM consists of free DNA, DNA-protein 
complexes (DNA·P) and free P (Figure 1.4a). A plug of EM is then 
introduced into the capillary and a high voltage is applied. The equilibrium 
fraction of DNA·P is separated from the equilibrium fraction of DNA by gel-
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free CE under non-equilibrium conditions (Figure 1.4b). Non-equilibrium 
conditions mean that the separation buffer does not contain DNA or 
protein. The unique feature of NECEEM in gel-free separation media is 
that free DNA molecules have similar electrophoretic mobilities, 
independent of their sequences. All free DNA molecules thus migrate as a 
single electrophoretic zone. The mobility of P, DNA and DNA·P depends 
on the separation conditions, with the mobility of DNA·P typically 
intermediate between that of DNA and P. Finally, a fraction is collected 
from the output of the capillary in a time window, which depends on the 
specific goals (Figure 1.4c). The widest aptamer collection window 
includes DNA·P complexes and DNA dissociated from DNA·P during 
NECEEM. The width and position of the window is an efficient stringency 
parameter, which can be used to select aptamers with predefined binding 
parameters. 
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Figure 1.4 NECEEM for selection and characterization of aptamers  
 
The unique feature of NECEEM is its very low background: the amount of 
non-aptamers collected in the aptamer-collection window normalised by 
the amount of the library loaded is approximately 10-5, which is two orders 
of magnitude better than the lowest previously published backgrounds. As 
a result, NECEEM requires as few as one round of selection. So far, three 
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rounds of NECEEM-based selection have been sufficient to reach a level 
of affinity which cannot be improved upon.  
 
Aptamer development requires measurement of the binding parameter of 
the target protein with (i) a naïve library, (ii) aptamer-enriched libraries, 
and (iii) individual aptamers. Conventionally, filter binding assays are used 
to measure equilibrium dissociation constants, Kd, for the three 
applications listed. Filter-binding assays are labour-intensive, time-
consuming, and semi-quantitative. Moreover, they cannot measure rate 
constants, kon and koff, which characterise the dynamics of complex 
formation and dissociation.  
 
NECEEM allows such an assessment through the determination of the 
average dissociation constant, Kd, as the DNA pool undergoes further 
rounds of selection. Both the unimolecular rate constant koff and Kd can be 
obtained from a single electropherogram. The value of kon can then be 
calculated: kon = koff/Kd. Free DNA library (or aptamer), P and DNA·P 
complex set up the following equilibrium: 
 
DNA + P   DNA·P 
 
The dissociation constant of the complex is defined as Kd = 
[ADNA ·AP]/ADNA·P whereby ADNA, AP and ADNA·P are the equilibrium 
kon
koff
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concentrations of free DNA, P and DNA·P complex. The amount of each 
component present is proportional to their respective peak areas in the 
NECEEM electropherogram, thus the values of ADNA, AP and ADNA·P can be 
substituted with the magnitudes of the individual peak areas. However 
since P cannot be detected, AP is not known. Thus, Kd has to be 
alternatively determined based on ADNA and ADNA·P as well as the total 
initial concentrations of DNA and P added into the mixture. Using the 
conservation of mass principle, the dissociation constant equation can be 
rewritten as: 
 












Where [P]o and [DNA]o are the initial concentrations of P and DNA in the 
equilibrium mixture. ADNA is the peak area of the free DNA; Adiss is the area 
of the exponential smear left by DNA dissociated from DNA·P during the 
separation; and ADNA·P is the area of the peak corresponding to the 
complex, which remained intact at the time of passing the detector. For 
multiple complex peaks, the peak areas were summarized for calculation 
of bulk affinity. The peak areas can be directly determined from the 
electropherograms. To obtain the correct values of ADNA and Adiss, the 
apparent areas of the corresponding peaks in NECEEM 
electropherograms are divided by the migration time of free DNA. As for 
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the correct value of ADNA·P, the apparent area of the corresponding peak in 
NECEEM electropherogram is divided by the migration time of this peak 
(or average migration time for multiple complexes). Generally, the smaller 
the Kd, the higher the affinity between ligand and protein.  
 
The aggregate value of koff of the protein-aptamer complex can also be 
estimated by analyzing the areas corresponding to the intact complexes, 
ADNA·P, and dissociated complexes, Adiss using Equation 1.5.   
 







+= DNA·PDNA·P /ln      
Where tDNA·P is the migration time of the DNA-protein complex. 
 
An advantage of NECEEM is that areas and migration time associated 
with the protein are not used in the calculations. This means that 
fluorescence detection can be used, with only DNA being fluorescently 
labelled. This is inexpensive and can be performed in a way that does not 
affect DNA·P binding [41]. Hence, the original DNA library was purchased 
with a fluorescent label and enriched DNA pools after each round of 
selection were labeled during PCR amplification in the presence of FAM-
tagged 5’-primer.  
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The high speed of NECEEM makes it possible to monitor the improvement 
of affinity during aptamer selection by measuring Kd of aptamer-enriched 
libraries at every round of selection. Importantly, this monitoring does not 
require additional experiments as electropherograms recorded during the 
partitioning of aptamers (Figure 1.4c) can be used for the calculation of Kd. 
In addition, NECEEM allows us to kinetically characterise all selected DNA 
molecules before sequencing them. When aptamers are selected and 
kinetically characterised (i.e. Kd and koff are determined), they can be used 
for quantitative analyses of the targets for which they are selected. 
NECEEM-based determination of Kd and koff is fast, accurate, and has a 
wide and adjustable dynamic range. The upper limit of Kd values depends 
on the highest concentration of P available, which allows measurement of 
Kd values for very low bulk affinities of naïve libraries. The lower limit on 
the other hand depends on the concentration limit of detection, where it 
can be as low as picomolar for fluorescence detection. With reference to 
Equation 1.5, the dynamic range of koff values is defined by the migration 
time of the complex, which can be easily regulated by the length of the 
capillary, electric field, or electroosmotic velocity. The practically proven 
dynamic range of koff spans from 10-4 to 1s-1 [37]. 
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1.1.5 Non-SELEX 
Non-SELEX selection of aptamers is a modified process from CE-SELEX 
developed by Krylov et al. [20], which involves repetitive steps of 
partitioning with no amplification between them (Figure 1.5).  
 
Figure 1.5 Difference between traditional SELEX and non-SELEX 
selection of aptamers 
 
Excluding the intermediate steps of PCR amplification and strand 
separation leads to a number of significant advantages of non-SELEX 
over SELEX, including: (1) speed and simplicity: non-SELEX selection 
saves time and can be performed in an automated fashion using a single 
commercially available capillary electrophoresis instrument; (2) 
quantitative errors associated with the exponential nature of PCR 
amplification are avoided, thereby making non-SELEX a useful tool for 
studies of the properties of DNA libraries with respect to their interaction 
with targets; (3) ability to accurately determine the abundance of aptamers 
in the naïve library, which makes non-SELEX a powerful tool in studies of 
fundamental properties of DNA libraries; (4) bias related to differences in 
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avoided;  (5) potential applicability to non-amplifiable libraries, such as 
those of DNA-tagged small molecules obtained by DNA-templated 
synthesis [33]. Hence, non-SELEX can potentially provide a viable 
alternative to SELEX in the commercial development of aptamers. 
However, the main limitation of the implementation of non-SELEX with 
currently available commercial CE instrumentation is that only a fraction of 
the collected ligands can be sampled for the next step of non-SELEX [20]. 
 
The non-SELEX technique was adopted and optimized for the purpose of 
this work to obtain aptamers for signal transduction proteins, which have 
not been selected before. Cell division cycle 42 (Cdc42) belongs to the 
Rho family GTPases, which regulate signal transduction pathways via 
interactions with downstream effector proteins. Cdc42 binds to various 
target effector proteins such as p21-activated kinase (PAK) or Myotonic 
dystrophy kinase-related Cdc42-binding kinase (MRCK) that 
phosphorylate proteins involved in organizing actin structures responsible 
for forming stress fibres, lamellipodia or filopodia. Therefore, it is of 
interest to find the specific effects of these kinases on cell shape for the 
investigation of the exact mechanisms which underlie cell migration and 
differentiation. This should facilitate the design of simple molecules to 
regulate relevant enzymatic action or protein-protein interactions. Such 
simple molecules will be able to provide the basis for therapeutic 
intervention in a variety of disorders, since these Rho GTPase switches 
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are implicated in a plethora of cellular processes. Hence, it is of interest to 
select highly specific aptamers that recognize and bind to these proteins 
selectively. The aptamers obtained for Cdc42, PAK and MRCK will have 
significant applications in the field of bioanalytical and biomedical sciences 
as aforementioned.  
 
1.2 Applications of aptamers 
The advantages of aptamers have led to numerous publications on their 
applications in the field of bioanalytical and biomedical sciences, including 
affinity chromatography [42, 43] and capillary electrophoresis [44], 
proteomics and development of bioanalytical assays [45], inhibition of 
enzymes and receptors [46-55], development of artificial enzymes 
(ribozymes and aptazymes [19, 56-60]), target validation [3] and screening 
for drug candidates, cytometry and imaging of cellular organelles [61-63], 
development of biosensors [64-76], and even stem cell purification [77-81]. 
Aptamers are also gaining reputation as therapeutic reagents for the 
treatment of different pathologies, with their potential medical applications 
in gene therapy and drug delivery to therapeutic targets [82, 83]. Aptamers 
have been selected for coagulation factors [84-86], growth factors or 
hormones [87-90], antibodies involving autoimmune disease [91], 
inflammation markers [92, 93], virus related infectious diseases [94-105], 
membrane biomarkers [106-113], whole organisms and intact cells [114]. 
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Due to the growing importance for disease prognosis, development of new 
techniques for detection of gene and protein expression in cells to enable 
early therapeutic intervention is at the forefront of current research 
direction. Existing imaging techniques have led to unprecedented 
improvements in disease detection and characterization, especially in the 
area of oncology. For example, currently available clinical imaging 
systems like X-rays and MRI (magnetic resonance imaging) provide 
physical measurements of disease markers such as tumour size. 
Unfortunately, these are often late expressions of molecular abnormalities 
within cancer cells. This led to the increasing research interest in cellular 
MRI [115-119]. On the other hand, other imaging studies such as PET 
(positron emission tomography) scans and SPECT (single photon 
emission computed tomography) scans are radionuclide-based and costly 
[120, 121].  
 
Hence, it is desirable to develop a new and safe form of imaging system 
aimed at early disease detection. The novel method should be able to 
provide information on the molecular level, e.g. the cellular expression 
levels of oncogenes and oncoproteins directly involved in cancer-
associated processes. Aside from medical diagnosis, such molecular 
based imaging technique will also allow monitoring of biological pathways 
of proteins and mRNA inside living cells, for the study and understanding 
of cellular behaviour [122].  
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Molecular beacons (MBs) have become a leading oligonucleotide probe 
used in a variety of applications involving DNA⋅DNA and DNA⋅RNA 
hybridization studies and recently, protein-DNA interactions in solution 
[123]. The ability of MB probes to detect specific target molecules without 
separation of unbound probes also provides an opportunity to detect 
intracellular mRNA and protein molecules in intact cells. The development 
of MBs for the detection of DNA and mRNA has been established with the 
ease of obtaining highly specific probe sequences based on the 
complementary target gene sequences, which are readily available in the 
GenBank. However, it is not so straightforward for protein targets. 
Therefore, the aim of this work is to combine the binding specificity of 
aptamers with the signal transduction mechanism of MBs for the 
development of molecular aptamer beacons (MABs) [18]; and to look into 
one of the interesting aspects of the applications of aptamers by studying 
the possibility of imaging these proteins in cells. The success of MABs can 
facilitate the study of biological pathways in living cells, which will be of 
great therapeutic importance. 
 
The scope of this thesis comprises the selection of aptamers for different 
signal transduction proteins, i.e. Cdc42, PAK and MRCK, which was 
achieved through the optimization of non-SELEX conditions, where 
binding affinities of aptamers obtained for each protein were determined 
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using NECEEM. A representative MRCK aptamer was then modified for 
the development of aptamer probes. Selectivity studies of the aptamer 
probe in solutions and preliminary experiments on the binding specificity of 
aptamer in a cellular environment were carried out to identify challenges to 
be overcome for future development of aptamer probes. 
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Chapter 2 Selection of aptamers for signal transduction 
proteins by capillary electrophoresis 
2.1 Introduction 
2.1.1 Signal transduction protein as targets of interest 
Cell migration is an essential event observed in wound healing, immune 
surveillance, and during the growth and development of multicellular 
organisms. It is controlled by internal and external signals, such as 
attractants or repellants from distant environment, neighboring cells or 
extracellular matrix (ECM) [124]. These signals in turn activate complex 
signal transduction cascades that result in highly dynamic changes in 
actomyosin cytoskeleton, microtubules, vesicular transport pathways, 
genes transcription and protein-protein interaction. There are a wide 
variety of intracellular signaling molecules implicated in cell migration, 
including MAPK cascades, lipid kinases, phospholipases, serine/threonine 
and tyrosine kinases and scaffold proteins. Rho GTPase is one particular 
family of proteins that appears to play a pivotal role in regulating the 
biochemical pathways most relevant to cell migration. 
 
The Ras-related Rho family of GTPases constitutes small signaling G 
proteins with molecular weight typically around 21 kDa. These GTPases 
act as molecular switch to control complex cellular processes by shuttling 
between two conformational states, the inactive GDP-bound form and the 
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active GTP-bound form. The GTP-bound state of Rho GTPases interacts 
with their respective downstream effectors to generate a response till they 
hydrolyse GTP to GDP, while the GDP-bound state of Rho GTPases 
remains inactive. There are 60 effectors of Rho GTPases that have been 
identified so far. Cdc42 is one of the best-characterized target proteins, 
which was reported to induce the formation of actin-rich membrane 
extension structures called filopodia [125, 126]; and involved in the 
establishment of cell polarity [127]. The downstream effectors of Cdc42 
include PAK [128] and MRCK [129] that belong to a family of 
serine/threonine kinases. There are various isoforms of PAKs and MRCKs. 
For the purpose of this work, PAK1 and MRCKα were used for aptamer 
selection.  
 
Non-SELEX was the method of choice for the selection of aptamers for 
these signal transduction proteins. Various experimental conditions, 
including (1) type and length of capillary, (2) sample injection volume, and 
(3) type, pH and concentration of run buffer and incubation buffer were 
optimized. The optimization of PCR conditions was also done to ensure 
high purity of enriched libraries obtained through the aptamer selection 
process. Subsequently, binding parameters of the aptamers obtained 
were determined using NECEEM partitioning to identify the best binders, 
which were used for application studies in Chapter 3. 
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2.2 Materials and Methods 
2.2.1 Materials 
Active mutant cell division cycle 42 GTP binding protein (Cdc42-GTP) and 
wild type Cdc42-GDP (21 kDa; pI 5.255), recombinant human p21-
activated kinase protein 1 (PAK1) and inactive PAK1 (62 kDa; pI 5.686), 
MRCKα kinase domain (MRCKα-KD) and its kinase dead mutant (54.4 
kDa; pI 4.954) were prepared as described earlier [130, 131] by Ms Jesyin 
Lai from Institute of Molecular and Cell Biology, Singapore. The molecular 
weight of MRCKα is around 197 kDa (pI 6.549), which is too big to be 
prepared by E. Coli bacteria. Therefore, the kinase domain (MW 54.4 kDa, 
pI 5.08) that determines the active or inactive form of MRCKα was 
prepared instead for the selection of aptamers. It was predicted that the 
high specificity of aptamers will have the capacity to distinguish various 
forms of MRCK even if there was only a slight difference in structure.   
 
Carboxyfluorescein (FAM) labeled random naïve single-stranded (ss) DNA 
library, synthesized by manual mixing to ensure a 1:1:1:1 ratio of the four 
nucleotides in the randomized region of the library, was bought from 
Integrated DNA Technologies (Coralville, IA, USA). The DNA library 
consisted of a central 40-base random region flanked by two 20-base 
primer regions: 5’-/6-FAM/ AGC AGC ACA GAG GTC AGA TG (40N) TTC 
AGC GTA GCA CGC ATA GG-3’. A 100 µM stock solution of the library 
was prepared in Tris-EDTA (TE) buffer (1st Base, Singapore) and stored at 
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-20 °C. A FAM-labeled forward primer: 5’-/6-FAM/- AGC AGC ACA GAG 
GTC AGA TG-3’ and biotin-labeled reverse primer: 5’-/Biotin/-TTC AGC 
GTA GCA CGC ATA GG-3’ were purchased from Aitbiotech (Singapore). 
The forward primer was fluorescent-tagged to facilitate fluorescence 
detection of enriched ssDNA library after PCR, while the reverse primer 
was biotinylated to enable isolation of ssDNA after PCR using a 
streptavidin-agarose column (Millipore, Singapore). The primers were 
resuspended in TE buffer to a concentration of 10 µM and stored at -20 °C. 
Unlabeled primers were also purchased and stored in the same manner. 
Sodium hydroxide (Fluka, Singapore) and hydrochloric acid (Fisher 
Scientific, Singapore) were used to prepare capillary rinsing solutions. The 
following are reagents that were used for PCR: Vent Taq polymerase and 
dNTP solution were from New England Biolabs, Inc. (Ipswich, MA, USA), 
and GenElute® miniprep kit from Sigma-Aldrich (Singapore). 
 
2.2.2 Buffers 
Ready-made sodium phosphate buffer was purchased from 1st Base. Tris 
buffer was prepared from Tris-HCl (Promega, Singapore) and Trizma® 
base (Invitrogen, Singapore); sodium borate buffer was prepared from 
sodium borate and boric acid (Merck). Varying amounts of sodium chloride 
(Sino Chemical, Singapore) and magnesium chloride (Riedel-de Haën, 
Singapore) were used in the optimization of selection buffers. The 
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following run buffers (RB) and selection buffers (SB) were prepared based 
on optimized conditions for the respective proteins: 
Cdc42-GTP (RB: 20 mM sodium phosphate buffer, pH 8; SB: 10 mM tris 
buffer, pH 8); PAK1 (RB: 100 mM borate buffer, pH 9; SB: 50 mM tris, 100 
mM NaCl, 5 mM MgCl2, pH 8); MRCKα-KD (RB: 50 mM sodium 
phosphate buffer, pH 7; SB: 50 mM tris, 50 mM NaCl, 5 mM MgCl2, pH 8) 
 
All buffers were made using Milli-Q-quality deionized water filtered through 
a 0.22-µm filter (Millipore, Singapore) and sonicated at the beginning of 
each day before they were administered into the capillary. 
 
2.2.3 Equipment 
Polyimide bare fused silica capillary of 50 µm inner diameter and 360 µm 
outer diameter were purchased from Polymicro Technologies (Coralville, 
IA, USA). For PVA-coated capillaries, an uncoated fused silica capillary 
was flushed with 0.1 M NaOH, 0.1 M HCl and deionized water for 10 min 
each, followed by pushing all the liquid out of the capillary by nitrogen (or 
air). Next, PVA solution (10% w/w in water) was then forced through the 
capillary under pressure, followed by slowly discharging from the capillary 
under pressure. The final immobilization of the PVA coating was achieved 
by heating the capillary at 140°C for 3h under a gentle flow of nitrogen (or 
air). The lengths of the capillaries used were 60 cm in total (Ltot), 50 cm to 
the detection window (Leff). The detection window was made by burning off 
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the polyimide coating to reveal a short transparent section of about 0.5 cm. 
Prior to its first use, the uncoated capillary was rinsed with 1 M NaOH, 100 
mM HCl and ddH2O for 30 min each. CE procedures were performed 
using either a Beckman Coulter P/ACE MDQ apparatus equipped with 
fraction collection and photodiode array (PDA) detector (Mississauga, ON, 
Canada) or CE Resources (Singapore) portable CE-P2, equipped with 
laboratory-built laser-induced fluorescence (LIF) detector. The 
thermocyclers used for PCR amplification and denaturation of DNA 
samples were Applied Biosystems GeneAmp® PCR system 2700 or 
Eppendorf MasterCycler 5332.  
 
2.2.4 Procedure for non-SELEX 
2.2.4.1 Preparation of naïve DNA library 
5 µl of 100 µM naïve DNA library was mixed with 5 µl of 2 × selection 
buffer, then denatured at 94 ºC for 10 minutes and cooled at a rate of 0.5 
ºC/s to 20 °C to allow proper folding of ssDNA oligonucleotides before 
incubation with the protein. 
 
2.2.4.2 Determination of library bulk affinity and aptamer collection 
window 
The aptamer collection window was determined before any selection of 
aptamers was carried out. The CE conditions including the type of 
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capillary and run buffer (i.e. buffer type, buffer pH, buffer concentration) 
were first optimized to facilitate the best quality separation of the proteins 
of interest from the naïve DNA library. The biological buffer types studied 
included sodium borate buffer, sodium phosphate buffer and tris buffer. 
The pH ranged from 7 to 9, and the buffer concentrations were between 
20 – 200 mM.  
 
For the determination of the protein migration time, 165 nl (5 psi × 15 s) of 
the target solution was injected into the capillary and subjected to CE 
separation in RB at 333 V cm-1 (Cdc42-GTP: reverse polarity using PVA-
coated capillary; PAK1 and MRCKα-KD: normal polarity using bare silica 
capillary) with PDA detection at 200 nm and 280 nm for protein targets. 
The detection wavelength λ at 200 nm was used due to the low 
concentration of proteins available, since detection of peptide bonds is 
more sensitive than aromatic rings at 280 nm. However, extra care was 
taken to identify any possible UV-absorbing species (e.g. buffer additives) 
at λ = 200 nm. The migration time of the target to the detector was 
determined. For the calculation of the migration time of any species to the 
end of the capillary, the migration time to the detector was multiplied by 
the following conversion factor (f): 
f = Ltot / Leff = 60 cm / 50 cm = 1.2 
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For the determination of the DNA migration time, 22 nl (1 psi × 10 s) of 
100 nM folded naïve DNA library was injected into the capillary and 
subjected to CE separation in run buffer at 333 V cm-1 with LIF detection. 
The migration time of the naïve DNA library to the detector was 
determined and the migration time to the end of the capillary was 
calculated as above. 
 
40 µl of equilibrium mixture, consisting of 100 nM folded naïve DNA library 
and maximum concentration of protein available (typically < 20 µM due to 
limitations during protein synthesis) was prepared in the selection buffer 
and incubated at room temperature for 15 min or longer if necessary, 
subjected to optimization. 22 nl of the equilibrium mixture was then 
injected into the capillary and subjected to NECEEM separation in the run 
buffer at 333 V cm-1 with LIF detection. The bulk Kd value of the DNA 
library to the protein was calculated using Equation 1.4 in Section 1.1.4 if 
DNA-protein complex peaks were observed.  
 
The aptamer collection window was then determined according to the 
illustration in Figure 2.1.  




Figure 2.1 Illustration of aptamer collection window determination when (a) 
the DNA·P complex peak was not detectable, and (b) DNA·P complex 
peak was detectable. The order of elution depended on the optimized CE 
conditions.   
 
2.2.4.3 Multi-step NECEEM-based partitioning 
5 µl of 50 µM naïve DNA library was incubated with 5 µl of 1 – 1000 nM 
protein in the respective optimized selection buffer, giving a final 
concentration of 25 µM naïve DNA library (a total of 2 × 1012 molecules) 
and 0.5 – 500 nM protein. Optimization of the concentration of protein was 
necessary as the selection started with a protein concentration of two 
(a) For undetectable DNA·P peak 

















(b) For detectable DNA·P peak 
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orders of magnitude below the bulk Kd of the naïve DNA library earlier 
determined.  
 
165 nl of the equilibrium mixture was injected into the capillary and 
subjected to NECEEM separation in the run buffer. The fraction in the 
aptamer collection window determined was collected in the outlet vial 
containing 5 µl of the protein solution in the selection buffer. The 
concentration of the protein was the same as the optimized concentration 
used for the preparation of equilibrium mixture. The collected fraction was 
incubated at room temperature for 15 min before repeating the selection 
procedure twice. The number of partitioning steps for non-SELEX was 
done up to three times. Further rounds did not improve the selection. The 
collected fractions from each step were stored at -20 °C before analysis. 
Between every CE separation, the uncoated capillary was rinsed with 
fresh aliquots (to prevent nucleic acid contamination) of 100 mM HCl, 100 
mM NaOH, ddH2O and run buffer for 2 min each to prevent contamination 
with the naïve DNA library. For PVA-coated capillary, only ddH2O and run 
buffer were used for rinsing.     
 
2.2.4.4 Determination of optimum number of cycles of preparative 
PCR 
The optimum number of cycles for amplification of the aptamer pools for 
subsequent analysis was determined by CE. Four identical 10 µl PCR 
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amplification reactions for the naïve DNA library or collected aptamer 
pools were prepared. Vent taq polymerase (0.06 U/µl), naïve DNA library 
as template, FAM-tagged forward primer (1.5 µM), biotinylated reverse 
primer (1,5 µM), MgCl2 (4 mM) and dNTPs (250 µM each) were used for 
PCR amplification. The PCR mixed sample was first denatured at 94 °C 
for 5 min. Subsequently, various number of cycles of denaturation (30 s, 
94 °C), annealing (30 s, 53 °C), and extension (20 s, 72 °C) were 
performed and the reaction was terminated after a final extension for 5 
min at 72 °C. 
 
One of the four vials was removed after 15, 20, 25 and 30 PCR cycles 
immediately after the polymerization at 72 °C. 22 nl of each PCR sample 
was injected into the capillary and CE was carried out in 25 mM borate 
buffer, pH 9.4 at 500 V cm-1. The fused silica capillary was of 50 µm inner 
diameter; 360 µm outer diameter; and the length of the capillary was 50 
cm in total, 40 cm to the detection window. CE separation of the PCR 
product from the F-FAM primer was observed with LIF detection. The 
optimum number of PCR cycles was chosen as the maximum number of 
cycles before formation of non-specific side products was observed.    
  
2.2.4.5 Preparative PCR of collected fractions for affinity analysis 
DNA in the collected fractions was PCR-amplified using the above 
procedure with the optimized number of cycles. The PCR products were 
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analyzed with gel electrophoresis at IMCB (details are provided in 
Appendix I) for confirmation of amplification efficiency. Note that the 
number of PCR cycles might vary from fraction to fraction and would 
require re-optimization.  
 
2.2.4.6 Separation of DNA strands 
Carboxyfluorescein-labeled DNA was separated into single-strands using 
a streptavidin-agarose column. The streptavidin agarose beads were first 
packed in a 1 ml blue tip and equilibrated with streptavidin binding buffer 
(10 mM Tris, pH 7.5, 50 mM NaCl, and 1 mM EDTA). The PCR product 
was diluted half with the streptavidin binding buffer and passed through 
the equilibrated streptavidin-agarose column. After the whole sample has 
passed through the column, it was washed with 1 ml of streptavidin buffer 
for 5 times. dsDNA with a biotinylated complementary strand would bind to 
streptavidin and remain in the column. Finally, the desired ssDNA 
aptamers were eluted with 400 µl of 0.15 M NaOH at 37 °C. 60 µl of 1 M 
HCl was added into the eluted fraction to bring the pH down to neutral. 
Ethanol precipitation was done to concentrate the eluted ssDNA and this 
formed the enriched pool of ssDNA aptamers. The concentration of the 
enriched fraction was estimated by measuring the OD at 260 nm. 
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2.2.4.7 NECEEM-based affinity analysis of enriched fractions 
Each enriched fraction was heat denatured as described for the naïve 
DNA library. 20 µl of 200 nM enriched fraction was mixed with 20 µl of 2 
µM protein solution to obtain a final concentration of 100 nM and 1 µM 
respectively. The mixture was incubated at room temperature for the 
optimized incubation time. 22 nl of the equilibrium mixture was injected 
into the capillary and subjected to NECEEM in the run buffer optimized for 
respective proteins at 333 V cm-1. The bulk Kd was calculated for each 
enriched fraction to the protein target using Equation 2.4.     
 
2.2.4.8 Cloning and sequencing 
DNA ligands obtained from the aptamer pool with the highest binding 
affinity were PCR amplified using unlabeled primers, ligated into pDrive 
vector and cloned into XL-1 Blue bacteria. Random colonies grown on 
agar plates were picked up and the plasmids from each colony was 
prepared and purified using a GenElute® Miniprep Kit. The vectors were 
then digested with ECoRI and DNA fragments with the correct cut size 
were sequenced. This part of the work was carried out at IMCB, 
Singapore. Further details on the procedure are given in Appendix I.  
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2.2.4.9 Screening of aptamers 
The FAM-labeled aptamers were chemically synthesized based on the 
sequences obtained. 100 µM stock solutions of aptamers were prepared 
in TE buffer and stored at -20 °C. NECEEM-based affinity analysis was 
done for the aptamers using the same procedure as that for enriched 
fractions. Kd was calculated for each aptamer using Equation 2.4.  
 
2.2.4.10 Sequence analysis  
Sequence analysis using the software ClustalW from the website 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) was carried out for the 
aptamers selected for each protein. A phylogenetic tree was generated to 
identify clusters and check for presence of consensus region to allow for 
truncation and possible improvement in binding. A nucleotide BLAST 
search using the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was 
done for the aptamers with the best binding affinity to find regions of 
similarity between biological sequences. 
 
2.3 Results and Discussion 
2.3.1 Optimization of non-SELEX conditions 
Signal transduction proteins used in this study, i.e. Cdc42, PAK and 
MRCK, were used as targets for which aptamers have never been 
previously selected. NECEEM-based non-SELEX was employed for the 
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rapid selection of aptamers for these proteins of different physical 
properties. During the analysis for each protein, careful measures were 
necessary to ensure that the proteins remained in its native state and 
maintained its activity. The storage conditions and duration vary 
depending on the type of protein; therefore these factors were taken into 
consideration during the optimization of incubation conditions. In general, 
incubation times of not more than an hour at room temperature were used 
to ensure high stringency of the selection process, where only aptamers 
that can bind rapidly with high selectivity were selected.  Moreover, the 
short incubation times maintained the activities of the proteins. It was also 
essential that the proteins have high purity to only select aptamers for the 
target and not the impurities. Hence, the freshly prepared proteins were 
purified in anion-exchange column using SMART for smaller scale or 
HPLC for larger scale prior to use. 
 
Aptamers were selected from a naïve DNA library with a random 
sequence of 40 bases flanked by two constant primer regions of 20 bases 
(overall 80 bases, 25 kDa). The PCR primers should be designed using 
appropriate software to eliminate self-dimers and hetero-dimers, according 
to standard primer-design considerations. However, the design used in 
this work was as reported in Mendonsa’s work [22].  
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Method development for NECEEM-based non-SELEX was first performed 
to determine the aptamer collection window for these new protein-aptamer 
analyses. By choosing a proper aptamer-collection window, aptamers with 
the desired kinetic and thermodynamic parameters can be developed. The 
width and the position of the aptamer-collection window define the quality 
of partitioning of the target bound DNA molecules from the excess of the 
unbound DNA; the better the aptamer-collection window is separated from 
the peak of the naive DNA library, the higher the efficiency of aptamer 
selection. Parameters optimized to obtain a wide collection window were 
the type, concentration and pH of the run buffer. Other non-SELEX 
considerations for high stringency during selection included (1) salt 
composition of selection buffer; (2) protein concentration and (3) sample 
injection size.  
 
2.3.2 Optimization of run buffer 
The CE run buffer was chosen to facilitate the best quality separation of a 
target from DNA. For the purpose of separating biological analytes, three 
types of physiological buffers are normally employed, namely tris, 
phosphate and borate buffers. In order to choose the most suitable buffer, 
the electrophoretic migration of the signal transduction proteins under 
each of the three buffers was determined at a suitable pH within their 
buffering range. The total salt concentration was also below 200 mM to 
prevent excessive Joule heating and interference with the subsequent 
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PCR reaction. With increasing run buffer concentration, the zeta potential 
of the capillary wall’s electrical double layer decreases. This lowers the 
EOF, resulting in longer migration time of the protein and DNA. Under 
physiological buffer pH 7 – 9, the proteins of interest (due to their 
respective pI values) and naïve DNA library are negatively charged. 
Based on estimated values, the naïve DNA library is more negatively 
charged at -80 than the proteins at any given pH within the range studied, 
and thus is expected to have an electrophoretic mobility of a greater 
magnitude in the opposite direction of the EOF under normal polarity for 
an uncoated capillary. Therefore, it is postulated that the naïve DNA 
library peak will appear after the protein under normal polarity; and when 
the EOF is reduced, the migration time of the naïve DNA library will be 
delayed to a greater extent as compared to proteins, resulting in a larger 
separation, i.e. wider aptamer collection window, between the two peaks. 
This would favour higher selectivity during the aptamer selection process. 
However, increased migration time would aggravate the problem of 
protein adsorption onto the capillary wall as the protein is retained longer 
in the capillary. In addition, at too high a buffer concentration, the EOF 
may not be strong enough to drag the anionic DNA library to the outlet 
detector. To minimize protein adsorption, a PVA-coated capillary with 
reverse polarity can be used instead, which also reverses the order of 
migration of the DNA library and protein. PVA-coated capillaries contain a 
permanently adsorbed layer of poly(vinyl alcohol). This coating minimizes 
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hydrophobic and electrostatic solute/wall interactions and eliminates EOF. 
The PVA coating is stable over a wide pH range even under basic 
conditions from 2.5 to 9.5. This stability allows use of a wide range of 
common CE buffers. Because the silica surface is covered, many proteins 
can be analyzed without the peak tailing found with uncoated capillaries. 
In addition, since EOF is eliminated, cumbersome washing procedures are 
unnecessary and migration time reproducibility can be improved. 
 
These are important factors affecting the optimization of the run buffer for 
maximizing the aptamer collection window. During optimization, a “blank” 
run on the buffer without the protein was performed to identify the 
presence of other non-protein peaks in the electropherograms that may be 
attributed to chromophoric components such as Triton X-100 present in 
the buffer from which the protein was prepared.  
 
2.3.2.1 Cdc42-GTP 
For the optimization of run buffer, a PVA-coated capillary was first used to 
minimize the problem of protein adsorption onto the capillary wall. The 
type of physiological buffers commonly used with coated capillary are 
phosphate and tris buffers. Borate buffer is not suitable due to 
complexation of the PVA's vicinal diol-groups with borate, which gives rise 
to a negative charge. This effect increases with pH of the borate buffer 
and the borate concentration, resulting in significant EOF. It was found 
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that 50 mM phosphate buffer pH 7.0 using PVA-coated capillary gave 
well-separated peaks of Cdc42-GTP and the naïve DNA library with a 
wide aptamer collection window (Figure 2.2). Based on the isoelectric 
point of Cdc42-GTP, the protein was likely to have a smaller negative 
charge and consequently a lower µep than the DNA library at pH 7.0. With 
the use of coated capillary and reverse polarity, the DNA library was 
expected to migrate before Cdc42-GTP as µeff was solely dependent on 
µep since there was no EOF. No further conditions were tested with 




Figure 2.2 Electrophoretic migration of Cdc42-GTP (UV detection at 200 
nm) and naïve DNA library (UV detection at 260 nm) using 50 mM 
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2.3.2.2 MRCKα 
In the case of MRCKα-KD, an uncoated capillary was used for 
optimization of run buffer as a reasonable aptamer collection window 
could not be determined for PVA-coated capillary under the concentration 
and pH range of phosphate and tris buffer studied (data not shown). With 
uncoated capillary, the peaks from MRCKα-KD and naïve DNA library 
were not well-defined under low concentrations of the run buffer. Hence, it 
was necessary to increase the buffer concentration to obtain a wider 
collection window but significant protein adsorption was observed to the 
extent that the protein peak was almost undetectable (Figure 2.3). This 
was likely due longer retention time of MRCKα-KD within the capillary. 
When borate buffer pH 9 was used, the protein peak could be detected 
even at high concentrations. At higher pH, the increase in EOF 
supersedes the decrease in EOF resulting from high concentration. 
However, when MRCKα-KD was incubated with the fluorescent-tagged 
naïve DNA library and subjected to CE separation using borate as the run 
buffer, no complex peak was observed using fluorescence detection. The 
rapid EOF may have caused poor separation of the complex formed. 
Phosphate buffer, on the other hand, gave significant complex peaks. This 
also suggests that aptamers with lower Kd can be obtained under these 
conditions. After a few steps of non-SELEX, aptamers selected typically 
have Kd two orders lower than the bulk affinity of the naïve DNA library. 
Hence, considering the effects of buffer type, concentration and pH, the 
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optimized run buffer was chosen to be 50 mM phosphate buffer pH 7 
(Figure 2.4). Under the optimized conditions, MRCKα-KD was observed to 
have a migration time earlier than the DNA library. For uncoated capillary, 
µeff of the analytes are a result of both µep and EOF. The µeff of MRCKα-
KD is smaller than the DNA library as its isoelectric point suggests a lower 
negative charge, which does not oppose the direction of EOF as 
significantly as the DNA library at normal polarity.    
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Figure 2.3 CE electropherograms on the effects of buffer type, 
concentration and pH on MRCKα-KD peak. Protein peaks are denoted by 
*. Unlabelled peaks are system peaks identified from a blank run.  
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The complexes were also found to have a migration time between the 
protein and DNA library. In the equilibrium mixture, aptamers that were 
bound to the protein became considerably bulkier. The negatively charged 
phosphate backbone of the oligonucleotides formed electrostatic 
interactions with positively charged functionalities within the protein 
structure, producing complexes that had an overall lesser negative charge. 
Hence protein-bound aptamers were expected to have an intermediate 
value of electrophoretic mobility. 
 
Figure 2.4 Electrophoretic migration of FAM-tagged naïve DNA library 
incubated with kinase-active MRCKα-KD (LIF detection using 488 nm 
Argon laser) using 50 mM phosphate buffer pH 7.0, uncoated 50 µm i.d. 
capillary and normal polarity 
 
2.3.2.3 PAK1 
Similar to MRCKα-KD, an uncoated capillary was used for optimization of 
run buffer for PAK1. Borate buffer pH 9 was found to give the most 
significant protein peaks and the DNA library was eluted at a much later 
time. This permitted a larger aptamer collection window of about seven 
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minutes, ensuring the least contamination during aptamer collection from 
nonbinding sequences. Under the optimum conditions of phosphate buffer 
or tris buffer, either the DNA library could not be eluted within a 
reasonable amount of time for the determination of the aptamer collection 
window; or the window interval is too small (data not shown). Optimization 
of the borate buffer concentration was also done concurrently. The 
respective electropherograms obtained for PAK1 migration under various 
concentrations are found in Figure 2.5. Generally, increased buffer 
concentration led to better separation of protein and protein buffer peaks. 
It was also observed that for concentrations below 100 mM, only a single 
protein peak can be found on the electropherogram. This suggests that 
the protein peak with the smaller migration time could have co-migrated 
with the protein buffer components at lower run buffer concentrations. 
Alternatively, it might be due to the product of borate and PAK protein 
complexation at higher run buffer concentrations. This is because only one 
protein peak was observed when phosphate or tris buffers was used, and 
borate has been reported to form hydrogen bonding with the amine 
nitrogen of lysine residues, an amino acid that can be found in abundance 
upstream of PAK’s catalytic domain. Further, when borate buffer 
concentration was above 100 mM, the naïve DNA library was not able to 
reach the detector within an hour of separation time. Hence, the optimum 
run buffer was determined as 100 mM borate buffer pH 9 as shown in 
Figure 2.6, which gave rise to PAK1 having a migration time earlier than 
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the DNA library. For the same reason as MRCKα-KD, the µeff of PAK1 is 
smaller than the DNA library as its isoelectric point suggests a lower 
negative charge, which does not oppose the direction of EOF as 
significantly as the DNA library at normal polarity. 
 
 
Figure 2.5 Electrophoretic migration of active PAK1 (UV detection at 200 
nm) using various concentrations of borate buffer pH 9, uncoated 50µm i.d. 
capillary and normal polarity. Protein peaks are denoted by *, while buffer 
component (Triton X-100) are denoted by #. Unlabelled peaks are system 
peaks identified from a blank run. 
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Figure 2.6 Electrophoretic migration of active PAK1 (UV detection at 200 
nm) and naïve DNA library (UV detection at 260 nm) using 100 mM borate 
buffer pH 9, uncoated 50µm i.d. capillary and normal polarity. Unlabelled 
peaks are system peaks identified from a blank run. 
 
2.3.3 Optimization of selection buffer and protein concentration 
Besides the run buffer, optimization of the selection buffer and protein 
concentration were required for the detection of complex peak within the 
aptamer collection window to improve the stringency of selection. When 
no complex peak is observed, the bulk affinity of the target to the naïve 
DNA library is too low. Possible solutions include increasing the target 
concentration or decreasing the concentration of NaCl in the selection 
buffer. Due to the limitations of protein synthesis for this work, high 
concentrations of proteins could not be obtained, thus the maximum 
concentration available was used with varying concentrations of NaCl. The 
ionic strength of the buffer would affect the DNA configuration, leading to a 
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change in sensitivity and kinetics of binding of the protein target [132]. For 
kinase-active MRCKα-KD, the optimized selection buffer that gave rise to 
complex peaks was found to be 50 mM tris, 50 mM NaCl and 5 mM MgCl2. 
As more than one complex peak was observed, it suggests that kinase-
active MRCKα-KD interacts with DNA with several stoichiometries. 
Attempts to remove non-specific binding using poly (dI:dC) as a non-
specific competitor was proven to be unnecessary. This was reinforced by 
studies done by Singhal and Otim [41]. For the calculation of bulk affinity, 
peak areas of all complexes were summarized. Since adsorption of 
species to capillary walls can cause tailing of electrophoretic peaks, the 
peak areas were divided by its corresponding migration times to ensure 
that peak areas are proportional to the amounts of the species. As for 
Cdc42-GTP and active PAK1, there were no detectable complex peaks 
under various conditions of selection and run buffer tested.  Another 
solution that favour complex formation would be to incubate the targets 
with the DNA library overnight but this would result in selection of lower 
affinity aptamers and the denaturation of proteins, causing them to lose 
their activities, and thus was not done. Hence, undetectable Cdc42-GTP-
DNA and PAK-DNA complexes were collected blindly within the aptamer 
collection window. The bulk affinity of naïve DNA library to the respective 
signal transduction proteins are tabulated in Table 2.1.  
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For the determination of protein concentration during non-SELEX, 
although lower target concentration can be used to increase the 
stringency of selection, it was subjected to the ability to select. Therefore, 
the starting concentration for the first step of non-SELEX used was 
typically two orders of magnitude below the bulk Kd of the naïve DNA 
library determined as the selected aptamers will have an expected Kd 
value below the target concentration. However, a lower concentration was 
used in subsequent steps to only select aptamers with high affinity.  
 
Table 2.1 Estimated bulk affinities of the naïve DNA library for respective 
signal transduction proteins 
 
Proteins Kd of naïve DNA library / µM 
Cdc42-GTP > 104 
Active PAK1 > 104 
Kinase-active MRCKα-KD 150 
 
2.3.4 Sample injection size 
One of the advantages of using capillary electrophoresis for performing 
SELEX is the small amounts of analyte required. The sample injection size 
is typically in the scale of nanolitres. However, the shortcoming of this 
small volume would be the limited number of DNA library sequences that 
can be screened for binding at each round of selection. Library sequences 
are usually added in large excess so that competition for binding sites on 
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the protein will allow selection of the best binders from the pool. Large 
libraries also increase the probability of high-affinity aptamers present for 
selection. Hence, conventional SELEX normally utilizes libraries 
containing up to 1014 – 1015 sequences. Unfortunately, the capillary’s 
small dimensions pose a problem in loading this number of DNA 
molecules for non-SELEX. One solution is to use a high concentration 
library such that more sequences can be loaded along with the protein at 
each injection. However, higher concentrations of DNA are likely to give 
rise to broad, overloaded peaks that worsens the separation between free 
and target-bound DNA. More contamination from nonbinding sequences 
during aptamer collection may result, leading to a poorer partitioning 
efficiency. A library of concentration 25 µM with an injection pressure of 5 
psi for 15 s was thus chosen as a compromise between injection size and 
resolution. This loading size contained a total of 2 x 1012 sequences that 
were screened for binding with the proteins upon the first round of SELEX. 
 
2.3.5 Optimization of PCR conditions 
An efficient non-SELEX procedure has to be accompanied by efficient 
PCR amplification to obtain clean enriched aptamer pools for binding 
analysis. As PCR amplification in this work involves libraries of random 
DNA sequences, it is in essence different from PCR amplification of 
homogenous DNA templates. Product formation for a homogenous DNA 
template progresses until primers are depleted, however for a random 
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DNA library, production compilation halts when PCR primers are still in 
abundance. The products then promptly transmute into by-products. Thus 
the standard protocols of PCR amplification of homogenous DNA samples 
cannot be used on random DNA sequences. PCR thus have to be 
optimized for the amplification of the libraries that were collected during 
the non-SELEX process. PCR can yield undesired products due to 
amplification of different DNA sequences. GC rich regions can cause the 
formation of loop structures which will in turn cause polymerase skipping 
and production of shortened products [133]. Over-amplification may cause 
a complete loss of products as the PCR products are converted to by-
products, thus it is necessary for PCR amplification to be optimized. The 
naïve DNA library was used for PCR optimization with different number of 
cycle as it has the highest heterogeneity. The optimized conditions were 
then tested on collected aptamer pools to check the efficiency of PCR 
amplification as the DNA samples became less heterogenous. The 
electropherogram in Figure 2.7 shows the number of PCR cycles done on 
a random DNA library. When too few cycles were carried out, the yield 
would be too low and unreacted primers would be observed in the 
electropherogram. As the primers are single-stranded and has only 1 unit 
negative charge for each phosphate group as compared to the dsDNA 
which has 2 negative charges per base-pair, it does not oppose the 
direction of EOF as significantly as the dsDNA at normal polarity, thus the 
primers have an earlier migration time than the dsDNA. When 30 PCR 
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cycles were used instead, it resulted in the formation of by-products. 
Therefore, the PCR amplification procedure should not exceed more than 
25 cycles in a single step. It was concluded that the optimum number is 23 
cycles after further analysis with the first and fourth collected aptamer 
pools (Figure 2.8).  
 
Figure 2.7 CE electropherograms of PCR reaction mixtures for the 
amplification of the 80-nucleotide long random DNA library. Separation 
conditions were 25 mM borate buffer pH 9.4 at 500 V cm-1, uncoated 50 
µm i.d. capillary and normal polarity with LIF detection using 488 nm 
Argon laser.  
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Figure 2.8 CE electropherograms of PCR reaction mixtures for the 
amplification of the first (panel A) and fourth (panel B) aptamer pools. 
Separation conditions were 25 mM borate buffer pH 9.4 at 500 V cm-1, 
uncoated 50 µm i.d. capillary and normal polarity with LIF detection using 
488 nm Argon laser. 
 
2.3.6 Affinity studies for enriched aptamer pools 
To qualitatively monitor the progress of selection, the collected aptamer 
pools were PCR-amplified and the bulk Kd for the target–library interaction 
was measured to determine the effective abundance of aptamers in the 
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of the target with a highly heterogeneous DNA library as the value gives 
no indication of the Kd values of individual aptamers in the library. 
Nonetheless, a decrease of this value throughout the steps of partitioning 
gives an indication that the selection is progressing. After a few steps of 
non-SELEX, aptamers selected for Cdc42, MRCK and PAK were found to 
have Kd two orders lower than the bulk affinity of the naïve DNA library.  
 
2.3.6.1 Cdc42 
For Cdc42-GTP, four steps of positive selection and two further steps of 
negative selection were necessary to obtain aptamers with low micromolar 
Kd and selectivity against Cdc42-GDP. After three steps of positive 
selections, the complex peaks observed using LIF detection were very 
small (Figure 2.9) and there was no significant improvement in the bulk Kd 
from the 1st to 3rd enriched aptamer pool (Table 2.2).  
 
Table 2.2 Bulk affinities of 1st -3rd enriched Cdc42-GTP aptamer pools 
Enriched pool Selection type Kd / µM
1st + 32.0 
2nd + 50.9 




Chapter 2 Selection of aptamers for signal transduction proteins by capillary electrophoresis 
58 
Figure 2.9 Electrophoretic migration of 1st – 3rd enriched Cdc42-GTP 
aptamer pools incubated with Cdc42-GTP under optimized conditions. 
Separation conditions were 50 mM phosphate buffer pH 7.0, PVA-coated 
50 µm i.d. capillary and reverse polarity with LIF detection using 488 nm 
Argon laser. Enlarged view of the complex peaks is shown.  
 
With the knowledge of the migration time of the complex peak, which 
could not be observed for the naïve DNA library, the aptamer collection 
window was narrowed during the 4th step to only collect aptamers with 
strong affinity. The bulk Kd improved by one order for the 4th enriched 
aptamer pool but did not have significant selectivity against the structurally 
similar Cdc42-GDP (Figure 2.10). Cdc42-GTP and Cdc42-GDP only 
differs by one phosphate group, thus proves to be challenging to obtain 
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aptamers that could bind so specifically. Hence, two steps of negative 
selection using the 4th enriched aptamer pool with Cdc42-GDP were done 
to remove sequences that bind preferentially for Cdc42-GDP. Table 2.3 
compares the bulk Kd of Cdc42-GTP and Cdc42-GDP for the 4th to 6th 
enriched aptamer pools. Figures 2.11 and 2.12 give the 
electropherograms of the 5th and 6th enriched aptamer pools with 
improved binding affinity for Cdc42-GTP as indicated by more pronounced 
complex peaks observed. However, the negative selections did not 
effectively eliminate the affinity for Cdc42-GDP with the bulk Kd still in the 
same order as that for Cdc42-GTP. 
 
Table 2.3 Comparison of bulk affinities of 4th to 6th enriched Cdc42-GTP 






Kd for Cdc42-GTP / 
µM 
Kd for Cdc42-GDP / 
µM 
4th + 5.7 7.1 
5th  - 1.7 3.4 
6th  - 1.1 4.7 
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Figure 2.10 Binding affinities of 4th enriched aptamer pool (obtained after 
narrowing of aptamer collection window) with Cdc42-GTP and Cdc42-
GDP. Separation conditions were 50 mM phosphate buffer pH 7.0, PVA-
coated 50 µm i.d. capillary and reverse polarity with LIF detection using 
488 nm Argon laser  
 
 
Figure 2.11 Binding affinities of 5th enriched aptamer pool (obtained after 
1 step of negative selection from the 4th enriched pool) with Cdc42-GTP 
and Cdc42-GDP. Separation conditions were 50 mM phosphate buffer pH 
7.0, PVA-coated 50 µm i.d. capillary and reverse polarity with LIF 
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(c) 500 nM 5th enriched pool + 























(a) 4th enriched pool (blank run) 
(b) 500 nM 4th enriched pool  
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Figure 2.12 Binding affinities of 6th enriched aptamer pool (obtained after 
2 steps of negative selection from the 4th enriched pool) with Cdc42-GTP 
and Cdc42-GDP. Separation conditions were 50 mM phosphate buffer pH 
7.0, PVA-coated 50 µm i.d. capillary and reverse polarity with LIF 
detection using 488 nm Argon laser.  
 
2.3.6.2 MRCKα 
Enriched aptamer pools with nanomolar Kd for kinase-active MRCKα-KD 
were obtained just after two steps of positive selection of non-SELEX, 
unlike for Cdc42-GTP. This was due to the lower bulk affinity of the naïve 
DNA library for MRCKα-KD. Further selection did not improve the affinity 
as seen in Table 2.4. Figure 2.13 gives the electrophoretic migration of the 
1st to 3rd enriched MRCKα aptamer pools. Note that higher concentration 
of 1 µM kinase-active MRCKα-KD instead of 100 nM was used for the 
observations of complex peaks for the 1st enriched pool. A higher 
concentration of kinase-active MRCKα-KD would shift the equilibrium to 
favour the formation of protein-DNA complex. However, based on 
Equation 1.4, this would result in a higher calculated Kd. Therefore, the 
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(a) 6th enriched pool (blank run) 
(b) 500 nM 6th enriched pool + 
1 µM Cdc42-GTP 
(c) 500 nM 6th enriched pool + 
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bulk affinity decreases by an order although there was no significant 
increase in the complex peak areas from the 1st to 2nd enriched pool 
binding analysis.      
 
Table 2.4 Bulk affinities of enriched MRCKα aptamer pools 
Enriched pool Selection type Kd / µM
1st + 7.6 
2nd + 0.4 
3rd + 0.5 
 
 
Figure 2.13 Electrophoretic migration of 1st – 3rd enriched MRCKα 
aptamer pools incubated with MRCKα-KD. Separation conditions were 50 
mM phosphate buffer pH 7.0, uncoated 50 µm i.d. capillary and normal 
polarity with LIF detection using 488 nm Argon laser.  
 
2.3.6.3 PAK1 
Similar to Cdc42-GTP, active PAK1 required four steps of positive 
selection of non-SELEX. Table 2.5 summarizes the bulk Kd for the 1st to 
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4 (a) 100 nM1st enriched pool 
+ 1 µM active MRCKα-KD 
(b) 100 nM 2nd enriched pool 
+ 100 nM active MRCKα-KD 
(c) 100 nM 3rd enriched pool + 
100 nM active MRCKα-KD 
Complex peaks Free 
DNA 
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4th enriched PAK1 aptamer pools. It was observed from Figure 2.14 that 
the complex peak co-migrates with the free DNA peak as the aptamer 
collection window was chosen to span from the first PAK1 component to 
the close proximity of the library to ensure that no aptamers were missed. 
For the 4th enriched pool, an additional complex peak at an earlier 
migration time was observed. This suggests that aptamers with lower Kd 
were present within the 4th enriched pool. More than one complex peak 
also indicated that active PAK1 interacted with DNA at various binding 
sites whose complexes had different migration times. This was proven by 
incubating a higher concentration of active PAK1 with the 4th enriched pool, 
which led to the observation of more and larger complex peaks as shown 
in Figure 2.15. 
 
Table 2.5 Bulk affinities of enriched PAK1 aptamer pools 
Enriched pool Selection type Kd / µM
1st + 11.6 
2nd + 14.9 
3rd + 6.6 
4th  + 3.7 
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Figure 2.14 Electrophoretic migration of 1st – 4th enriched PAK1 aptamer 
pools incubated with active PAK1. Separation conditions were 100 mM 
borate buffer pH 9, uncoated 50µm i.d. capillary and normal polarity with 
LIF detection using 488 nm Argon laser. 
 
 
Figure 2.15 Electrophoretic migration of 4th enriched PAK1 aptamer pools 
incubated with higher concentration of active PAK1, giving rise to 
observation of more complex peaks. Separation conditions were 100 mM 
borate buffer pH 9, uncoated 50µm i.d. capillary and normal polarity with 























(b) 10 nM 4th enriched pool + 5 µM PAK1 
(a) 4th enriched pool (blank run) 
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(a) 10 nM 1st enriched pool + 1 µM PAK1 
(b) 10 nM 2nd enriched pool + 1 µM PAK1 
(c) 10 nM 3rd enriched pool + 1 µM PAK1 
(d) 10 nM 4th enriched pool + 1 µM PAK1 
Co-migrating 
complex peak 
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2.3.7 Sequence and binding analysis of aptamers 
After obtaining the enriched aptamer pools with reasonably good binding 
affinity for each protein target, randomly selected clones from the aptamer 
pool were sequenced to obtain the individual DNA sequences. Sequence 
alignment was done using ClustalW2 software to generate a phylogenetic 
tree. The software is useful for producing biologically meaningful multiple 
sequence alignments of divergent sequences. It also calculates the best 
match for the selected sequences, and lines them up so that the identities, 
similarities and differences can be seen. Based on the phylogenetic trees 
obtained for Cdc42-GTP (Figure 2.16), MRCKα (Figure 2.17) and PAK1 
(Figure 2.18), it was observed that there was no significant consensus 
region, thus non-SELEX was effective in the selection of numerous unique 
sequences that bound well to the target. Random sequences were then 
selected for binding analysis to determine how well each strand binds. 
Aptamers with truncated constant regions were synthesized and 
fluorescently labeled for screening. The truncated aptamers were used 
directly for affinity studies instead of the purified clones as the change in 
aptamer configuration after removing the primer regions may affect the 
binding ability. This in turn minimizes the time required for the 
identification of best binders. Very recently, Yunusov and co-workers [134] 
proposed a new method termed transverse diffusion of laminar flow 
profiles (TDLFP) / kinetic capillary electrophoresis (KCE) – based affinity 
analysis that can be applied to aptamer clones without an additional 
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purification step after asymmetric PCR amplification to improve the 
efficiency of the aptamer screening process.  
 
 
Figure 2.16 Phylogenetic tree of Cdc42-GTP DNA sequences from 6th 
enriched Cdc42-GTP aptamer pool 




Figure 2.17 Phylogenetic tree of MRCKα DNA sequences from 2nd 
enriched MRCKα aptamer pool 
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Figure 2.18 Phylogenetic tree of PAK1 DNA sequences from 4th enriched 
PAK1 aptamer pool 
 
Table 2.6 gives the summary of the top five binders for each signal 
transduction protein. The Kd of these sequences are in the low micromolar 
to nanomolar range, indicating high affinity to the protein target. The best 
binders were then subjected to sequence alignment as shown in Figure 
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2.19. No significant consensus region was observed, suggesting that each 
sequence is likely to bind to different sites of the proteins. In general, no 
cross-reactivity was observed between the aptamers for Cdc42-GTP and 
kinase-active MRCKα-KD with their respective structurally similar inactive 
forms; while PAK1 aptamers show some cross-reactivity, it maintained 
selectivity for active PAK1 against its inactive form. A representative 
electropherogram for each protein is shown in Figures 2.20 – 2.22. 
Electropherograms of other aptamers are given in Appendix II. 
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Table 2.6 Sequences and affinities of the best five selected aptamers for 
the respective signal transduction proteins 
 
Proteins No. Sequence Kd / µM 
C1 AGTTTGGCGGGTAGTGGATATCAAG
ACTATTTGATGCCGA 
2 ± 1 
C4 AGAGAGAAAGCCAACCATAGCAAAT
GATACGGAGATTTTG 
1.2 ± 0.4 
C8 TTCCGGCTATGGTTAAACAAAAGACT
AGGGAGGTTATTCA 
0.6 ± 0.3 
C10 AGAACAAAGTCAGGACGTTCCGAAC
TAATGATCCAATCAG 





1.0 ± 0.8 
P5 ACCCCTCTTACCCGAAGCGTTAAGC
GGTGGAGGCTGTCA 
0.21 ± 0.03 
P12 CTTTTATAGGATCGCACCTATGAATC
TAATAGTCAAGTCC 
0.6 ± 0.6 
P20 GTAGATTGAATTAATTGGAAGAGTCG
ATCAGTGTTTAATG 
0.15 ± 0.02 
P23 GGCGAGAACAGGTCGTCCGAGGGT
GACCCAACAAGGAAAA 




0.3 ± 0.1 




0.13 ± 0.06 
M16 CGAATACCTGGAGGAACACGGGAAA
AGATCACTGAAGCCA 
0.10 ± 0.01 
M31 CTACTGAATTTGGCTTTATAAGGGTT
ACGACCGTCCTCGT 
0.12 ± 0.04 
M40 CTTCGGCTTCACAGCTTTGGAAAGG
GTACAAATTAAACTA 




0.06 ± 0.03 
 







Figure 2.19 Sequence analyses of the best binders for (a) Cdc42-GTP, (b) 
PAK1 and (c) MRCKα 
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The representative Cdc42-GTP aptamer was incubated with either Cdc42-
GTP or Cdc42-GDP for an hour before binding analysis. A stable Cdc42-
GTP-aptamer complex peak with a small amount of dissociated complex 
forming the free DNA peak was observed in Figure 2.20b. Conversely, 
Figure 2.20c shows that no significant Cdc42-GDP-aptamer complex peak 
was detected. This indicates the high selectivity of the aptamer with the 
ability to distinguish one phosphate difference. In spite of the poor 
selectivity of the enriched Cdc42-GTP aptamer pools against Cdc42-GDP, 
the bulk affinity proves to only give an average Kd of the heterogenous 
DNA sequences while there are actually sequences present in the pools 
with higher selectivity and/or better affinity for the expected target.    
 
 
Figure 2.20 Binding affinities of representative Cdc42-GTP aptamer (C1) 
with Cdc42-GTP and Cdc42-GDP. Separation conditions were 50 mM 
phosphate buffer pH 7.0, PVA-coated 50 µm i.d. capillary and reverse 




















(a) Cdc42-GTP aptamer C1 (blank run) 
(b) 100 nM C1 + 1 µM Cdc42-GTP 
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For MRCKα aptamer, the incubation time required for the binding analysis 
was only 15 mins, which reinforces the high binding affinity of the 
aptamers as a short duration is required for complex formation. The rapid 
response advocates the potential application of MRCKα aptamers for 
diagnostic assays. Hence, selectivity studies were carried out with other 
proteins, e.g. thrombin and PAK1, in addition to its structurally similar 
kinase dead mutant (kinase-inactive MRCKα-KD). There were no 
observable complex peaks except for kinase-active MRCKα-KD, indicating 
the high selectivity of MRCKα aptamer as shown in Figure 2.21. Due to 
the high specificity and fast kinetics, the MRCKα aptamer will be employed 
for further application studies discussed in Chapter 3.   
 
 
Figure 2.21 Selectivity studies of MRCK aptamers. Electrophoretic 
migrations of (a) representative MRCKα aptamer (M6) without any 
proteins, and M6 aptamer incubated with (b) active MRCKα-KD, (c) 
inactive MRCKα-KD and (d) thrombin. Separation conditions were 50 mM 
phosphate buffer pH 7.0, uncoated 50 µm i.d. capillary and normal polarity 





















(a) MRCK aptamer M6 (blank run) 
(b) 10 nM M6  
+ 100 nM active MRCKα-KD 
(c) 100 nM M6 + 100 nM inactive MRCKα-KD 
(d) 100 nM M6 + 100 nM thrombin
Complex peaks 
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In comparison with Cdc42-GTP and MRCKα aptamers, PAK1 aptamers 
have slower kinetics and require incubation times of 3 hours or longer.  
Nonetheless, there was still good selectivity of PAK1 aptamer for active 
PAK1 against its inactive form, although not as considerable as in the 
cases of Cdc42-GTP and MRCKα. Inactive PAK-aptamer complex peak 
can be observed in Figure 2.22, where the Kd of aptamer P5 for active 
PAK1 was 211 ± 26.8 nM, while that for inactive PAK1 was 1 ± 0.1 µM. 
Further optimization of the selection buffer and negative selections of non-
SELEX did not improve the selectivity.  
  
 
Figure 2.22 Binding affinities of representative PAK1 aptamer (P5) with 
active and inactive forms of PAK1. Separation conditions were 100 mM 
borate buffer pH 9, uncoated 50µm i.d. capillary and normal polarity with 
LIF detection using 488 nm Argon laser. 
 
It was observed that the general pattern and the migration times of some 
protein-aptamer complexes were slightly different from those of the 
protein-DNA complexes of the enriched pools. This is most likely due to 
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(a) PAK1 aptamer P5 (blank run) 
(b) 100 nM P5 + 1 µM active PAK1 
(c) 100 nM P5 + 1 µM inactive PAK1 
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the truncated aptamer’s being considerably shorter than the DNA in the 
library (40 bases versus 80 bases). It also suggests that each protein has 
numerous recognition sites for aptamer binding, which is different from the 
protein’s active site. Therefore, aptamer selection is not restricted to DNA-
binding proteins but theoretically all kinds of proteins. Among various 
protein-DNA interactions, hydrogen bonds enhance specificity and aid in 
protein recognition. It was reported that DNA-backbone interactions and 
van der Waals contacts though numerous, mainly provide stability, whilst 
water-mediated bonds are usually non-specific, acting as space fillers at 
the protein-DNA interface [135]. 
 
2.4 Summary 
High affinity aptamers for Cdc42-GTP, PAK1 and MRCKα were 
successfully selected in the low micromolar to nanomolar range using 
non-SELEX. The method is simple, rapid and efficient. Non-SELEX can be 
easily employed for the selection of aptamers for any proteins of interest 
regardless of different physical properties. NECEEM-based partitioning in 
non-SELEX can thus serve as a universal tool in the development and 
utilization of oligonucleotide aptamers. Using CE as an instrumental 
platform, NECEEM facilitates (i) highly efficient selection of aptamers with 
the ease of control through adjustment of the aptamer collection window, 
(ii) accurate determination of binding parameters and their temperature 
dependencies under controlled temperature [136, 137], and (iii) using 
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aptamers for quantitation of targets. NECEEM can also facilitate selection 
of aptamers with predefined binding parameters and be used for affinity 
analysis of low affinity complexes by taking advantage of a rapidly 
decaying complex to calculate all equilibrium and kinetic parameters of the 
reaction in a single experiment. These parameters are essential for 
understanding the dynamics of regulatory biological processes. However, 
the main limitation for the implementation of non-SELEX with currently 
available commercial CE instrumentation is that only a fraction of the 
collected ligands can be sampled for the next step of non-SELEX. Hence, 
it is imperative to design a device to enable complete sampling. 
 
The selected aptamers for signal transduction proteins have great 
potential to be used as therapeutic or diagnostic tools and for the 
development of new drugs. Further analysis of the effect of bound 
aptamers on the enzymatic activity of the proteins will be useful in the 
determination of the possible applications. For aptamers that bind on the 
active site and show inhibitory properties, they can be exploited as drug 
leads; otherwise, they can be used for the detection of enzyme in situ in its 
active state without affecting the activity. The large numbers of aptamers 
with different Kd selected for each protein can be employed for multi-probe 
affinity analysis to detect protein targets in the range of concentration 
around their Kd values. The wide dynamic range of accurately measured 
concentrations will be useful for the studies of many physiological and 
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pathological processes [138]. For the application of aptamers in complex 
biological matrix, chemical modification on the DNA backbone such as 
bridged/locked nucleic acid of the naïve DNA library prior to non-SELEX 
would be necessary to enhance nuclease stability. This would require 
further research into other types of polymerases for effective DNA 
polymerase reactions [139] and to render a more robust non-SELEX 
method.     
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Chapter 3 Development of aptamer probes for cellular 
imaging of protein localization 
3.1 Introduction 
3.1.1 Aptamers for cellular imaging 
Aptamers have the potential to replace antibodies as new molecular 
probes with advantages described earlier. Examples of the applications of 
aptamers in cellular imaging have been published but still in its infancy 
and have not been fully exploited. DNA/RNA aptamers have specific 
target recognition but lack the signal transduction capability for detection 
purposes. Due to the simplicity in chemical modification, aptamers have 
been labeled using fluorophores [87, 106, 140, 141] and radionuclides [87-
89], or more recently, conjugated with dye-doped silica nanoparticles [142, 
143], gold nanoparticles [144, 145], superparamagnetic iron oxide 
nanoparticles [146] and quantum dots [107, 111] that facilitate cellular or 
in vivo imaging [63]. Among these works, established aptamers for protein 
targets such as thrombin and particularly cell surface proteins, e.g. 
tenascin-C, prostate-specific membrane antigen and αvβ3 integrin were 
commonly used.   
 
For the development of fluorescent probes targeting specific cells, current 
methodologies require the identification of cell surface protein markers, 
which rely primarily on antibody availability and flow cytometry, but many 
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cell surface proteins remain undetectable. With the ability to select 
aptamers for whole live cell, i.e. cell SELEX [147], probes that bind to 
proteins specific to the type of cells can be created without the explicit 
knowledge of the cell-surface proteins or any molecular changes 
associated with a particular cancer. There is also no need to purify specific 
molecular targets, and cell surface proteins remain in their native 
conformations throughout the selection process. Through cell SELEX, 
several aptamer sequences can be generated during one selection, and 
this panel of aptamers can bind several different cell-surface biomarkers. 
Aptamers for several cell types, including small cell lung cancer [148], liver 
cancer [149], and lymphomatic and myeloid leukemia [150] have been 
reported.  
 
However, aptamers for detection of protein localization within cells have 
yet been extensively exploited. It is thus of interest to study the feasibility 
of imaging protein localization within the cells beside cell surface proteins. 
This should provide new tools for identifying cancer cells in clinical 
samples, studying biological effects, and evaluating the effects of 
therapeutic reagents on specific molecular targets in cancer cells [151]. 
Changes in the expression of key proteins in the cellular signaling 
pathways are at the forefront of molecular abnormalities found in cancer. 
An increasing number of proteins involved in cell growth have been found 
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to be altered through multiple mechanisms of oncogene activation [11]. 
Therefore, one of the current challenges is to understand protein functions.  
 
Effective protein recognition mechanisms are necessary for monitoring 
proteins inside living cells for a better understanding of cellular behavior. 
Tracing proteins inside living cells would provide revolutionary means for 
studying many biological pathways. Although fluorophore-labeled 
antibodies have been used for living cell protein detection, usually only 
large aggregation of proteins can provide enough signal contrast, as the 
unbound antibodies are also fluorescent. Tracking target proteins using 
fluorophore-labeled antibodies is difficult, because the fluorescence signal 
of the antibody remains the same irrespective of whether the antibody is 
bound to the target protein or not [122]. Antibodies are also not easily 
synthesized and may be immunogenic [2, 152]. The green fluorescence 
protein (GFP) family can help to solve this problem by fusing GFP with 
host proteins. However, this requires using gene clone techniques and not 
all fusions are successful. It is thus clear that there is an increasing 
demand for the development of new molecular probes for real-time protein 
recognition in solution and in living specimen.  
 
As aforementioned, aptamers can be simply modified with a fluorescent 
label to enable cellular imaging. However, similar to fluorophore-labeled 
antibodies, aptamers based on this monochromophoric approach require 
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large aggregation of proteins for sufficient signal contrast during live cell 
protein detection, as the unbound aptamers are also fluorescent, thus 
driving the direction towards aptamer probe designs adopting the 
molecular beacon (MB) mechanism that have the potential to overcome 
this problem. 
3.1.2 Principles of molecular beacon 
A molecular beacon is an oligonucleotide, with a quencher-fluorophore 
pair attached to the 3’ and 5’ ends respectively. It undergoes a 
conformational change from a hairpin to open structure upon hybridizing to 
a complementary target, resulting in a fluorescent signal (Figure 3.1) [153]. 
The fluorophore absorbs photons energy and is promoted to an excited 
state. In the absence of a quencher, the fluorophore falls back to the 
ground state, and the excess energy is released as fluorescence [154]. 
The quencher conversely absorbs the energy emitted by a fluorophore. 
Through FRET, it emits the energy at a different wavelength, reducing the 
fluorescence of the fluorophore. Alternatively, the quencher may act 
through collisional quenching, where the fluorophore and quencher are in 
close contact. The fluorophore transfers its energy to the quencher (which 
may be another fluorophore), and the energy is released from the 
quencher as radiative decay (i.e. fluorescence) at a higher wavelength. 
The efficiency of the process is dependent on 1/r6 (Förster distance), 
where r is the fluorophore-quencher distance. Probes incorporating non-
fluorescent dark quenchers have lower background fluorescence, 
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providing greater sensitivity. Dark quenchers absorb broadly and do not 
emit light, thus simplify detection, making them compatible with a broad 




Figure 3.1 Working principle of molecular beacons 
3.1.3 Aptamer probe designs 
Although the original goal for developing MB is for nucleic acids detection, 
recently MB has found promising applications in the homogeneous 
detection of DNA-binding proteins [155-159]. The mechanism of MBs 
opens a new approach to detect protein in homogeneous solution with 
high sensitivity, excellent reproducibility, fast speed and convenience. An 
apparent and critical disadvantage for the application of MBs in protein 
recognition is the lack of sequence specificity in protein binding. Aptamers 
have the potential to overcome this problem with the advantage of binding 
specificity and generality. Unlike MBs, aptamers lack the built-in 
mechanism for signal transduction, thus it is desirable to combine the 
binding specificity of aptamers with the signal transduction capability of 
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Beside modifying an aptamer with a fluorescent label with Figure 3.2a 
showing one possible method, there have been reports on the 
development of using aptamers for protein recognition with a similar signal 
transduction as in MBs but with varied designs [160]. Some of them were 
more suited for solution assays rather than cellular imaging. For example, 
Yamamoto et al. developed an aptamer to detect Tat protein of HIV-1 
[161]. A duplex RNA aptamer was split into two portions, with one portion 
transformed into a DNA probe, and with the other portion partly 
complementary to the DNA probe. The two portions could not hybridize 
until Tat protein was present, and the hybridization caused restoration in 
the otherwise quenched fluorescence. Similarly, Heyduk and Heyduk 
developed molecular beacons by splitting the DNA binding site of 
sequence-specific DNA-binding proteins (i.e. thrombin and catabolite 
activator protein) into two DNA “half-sites”, which will associate in the 
presence of the target protein to generate a spectroscopic signal [155, 
157]. In these studies, the bimolecular association reaction between the 
two portions is the overall rate-limiting step when the molecular beacons 
are applied in assays. Hence, Knoll and Heyduk further improved the 
design by creating a unimolecular beacon for catabolite activator protein 
(CAP) to reduce the response time (Figure 3.2b) [156].  
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For in vivo purposes, a two portions aptamer beacon design is not suitable. 
Instead of splitting the aptamer into two portions, Tan et al. designed a 
quenching-type molecular aptamer beacon for its application in assays 
based on the close conformation of the platelet-derived growth factor 
(PDGF) aptamer upon binding to the target [162, 163]. Similarly, Li et al. 
made use of the conformational change when thrombin aptamer was 
bound to the protein (Figure 3.2c). The authors claimed that while the 
quenching-type molecular aptamer beacon is suitable for homogeneous 
quantitation of target proteins in real time, it is less favourable for 
monitoring proteins in living specimen as the decrease in fluorescent 
signal upon binding makes it hard to detect minute amounts of protein and 
to trace a target protein in a living cell. Hence, they suggested that a 
protein probe needs to produce a signal increase when it recognizes 
target proteins [122].  
 
When modifying an aptamer into a probe, the conformational change of 
the aptamer in the presence of its target would affect the decision in 
designing a quenching or FRET-type MAB. For most aptamers, the 
conformational change is unknown unless NMR analysis and X-ray 
crystallographic studies were performed. In silico selection of RNA 
aptamers through three-dimensional (3D) structure prediction have 
recently been reported [21] but have yet been done for single-stranded (ss) 
DNA aptamers. Therefore, it may be possible to modify ssDNA aptamers 
Chapter 3 Development of aptamer probes for cellular imaging of protein localization 
86 
into the hairpin structure to adopt a similar reporting mechanism as MBs 
for the design of DNA MABs as shown in Figure 3.2d. Aptamers for 
ssDNA-binding proteins, such as E.Coli SSB protein [158] and lactate 
dehydrogenase (LDH) [164], have been exploited for such a design. 
Hamaguchi et al. [165], on the other hand, constructed a thrombin-binding 
aptamer beacon by adding a half stem sequence to the thrombin aptamer 
to change the aptamer into a MB form. A fluorophore-quencher pair was 
used and upon protein binding, the MB form was changed back to an 
aptamer form (G-quartet conformer), restoring the quenched fluorescence. 
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Figure 3.2 Various approaches for aptamer probe design. (a) 
Monochromophoric labeled aptamer (b) Unimolecular beacon for 
sequence-specific DNA-binding proteins (c) Bischromophoric labeled 
aptamer (d) Hairpin molecular aptamer beacon for single-stranded DNA-
binding proteins (Note: a half stem sequence can be added to the 5’ end 
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3.1.4 MRCKα as protein target for probe design 
MRCK belongs to a family of serine/threonine kinases which are highly 
related to the myotonic dystrophy protein kinase (DMPK) [166, 167] and 
Rho-associated kinases (ROKs/ROCKs/Rho-kinases) in term of protein 
sequences similarity and their downstream phosphorylation targets [168-
170]. Multiple functional domains were discovered and characterized from 
MRCKs. All the isoforms of MRCKs, including MRCKα, MRCKβ and 
MRCKγ, contain a highly conserved N-terminal serine/threonine kinase 
domain. MRCKα was found to bind more strongly to Cdc42-GTP than to 
Rac1-GTP and acts as an effector of Cdc42 that has the function of 
promoting cystoskeletal reorganization [129]. Previous studies show that 
MRCKα has implication in Cdc42-mediated peripheral actin formation and 
neurite outgrowth in HeLa and PC12 cells respectively [171], and the 
mechanism in which MRCKα regulates actin cytoskeletal reorganization is 
via phosphorylation of a myosin binding subunit of protein phosphatase 1 
(PP1) [172] and myosin light chain 2(MLC2) [173]. MRCKα also forms a 
tripartite complex with LRAP3a (Leucine repeat adaptor protein) and 
myosin 18a, and is involved in modulating lamellar actomyosin retrograde 
flow that is crucial to cell protrusion and migration [174]. 
 
In this work, the methodology as described by Hamaguchi et al. was 
implemented to design a molecular aptamer beacon for a newly selected 
MRCKα aptamer. The G-quartet conformation of the thrombin aptamer 
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has been well-established, leading to its use as proof-of-concept for many 
different beacon designs [175-179]. However, it is not known if such 
designs are readily applicable to other aptamers besides thrombin 
aptamer. By applying the reported beacon design by Hamaguchi to a new 
aptamer sequence with unknown conformation upon target-binding, 
preliminary studies of the MAB design was done for its feasibility to be 
applied to aptamers selected for other proteins of interest. Concurrently, 
the MRCKα aptamer was fluorescently-tagged to study its binding 
specificity for MRCKα within the cells prior to modification into MAB. The 
success of aptamers as protein probes for live cell applications can 
facilitate the study of the effect of drugs on cells through perturbation of 
protein localization and aid in understanding biological pathways, which 
will be of great therapeutic importance.  
 
3.2 Materials and Methods 
3.2.1 Materials 
MRCKα kinase domain (MRCKα-KD) and its kinase dead mutant were 
kindly prepared as described earlier [130, 131] by Ms Jesyin Lai (Institute 
of Molecular and Cell Biology, Singapore). The following were bought from 
Invitrogen (Singapore): Dulbecco’s Modified Eagle Medium (DMEM), 10 % 
fetal bovine serum (FBS), penicillin/streptomycin solution and mounting 
medium ProLong® Gold. Anti-HA (12CA5) primary antibody, anti-MRCKα 
primary antibody, anti-mouse Cy3-conjugated secondary antibody, 4'-6-
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Diamidino-2-phenylindole (DAPI), paraformaldehyde (PFA) and Triton X-
100 were purchased from Sigma Aldrich (Singapore). Ready-made 
Dulbecco’s phosphate buffered saline (DPBS) without Ca2+ and Mg2+ was 
obtained from PAA Laboratories GmbH (Pasching, Austria). Molecular 
aptamer beacons in Table 3.1 and fluorescently-labeled oligonucleotides 
in Table 3.2 were synthesized by Sigma-Proligo (Singapore).  
 
Table 3.1 Molecular aptamer beacon abbreviations and their respective 
sequences 
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3.2.2 Design of molecular aptamer beacons 
Secondary structures of DNA aptamers were predicted using mFold 
software from the website 
(http://eu.idtdna.com/Scitools/Applications/mFold/) for the design of 
molecular aptamer beacons.  
 
3.2.3 Selectivity studies for MRCKα molecular aptamer beacon 
The MAB was diluted to a concentration of 10 µM in TE buffer, heated to 
95 °C for 3 min and cooled to room temperature to ensure proper folding 
prior to the experiment. Fluorescence measurements were performed in 
the optimized aptamer selection buffer, i.e. 50 mM tris buffer pH 8.0, 50 
mM NaCl and 5 mM MgCl2. 0.5 µM of MAB was incubated for 1 h with a 
range of MRCK concentrations (0 – 2.5 µM) diluted to a final volume of 
100 µL. Further selectivity studies with the structurally similar inactive form 
of MRCK and a mismatched MAB were used. Fluorescence was read by 
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BioTek Synergy™ 4 Multi-Mode Microplate Reader with Hybrid 
Technology™ in 96-well microtitre plates. The wavelengths for excitation 
and emission (Ex/Em) of carboxyfluorescein are 485 nm and 520 nm 
respectively. 
 
3.2.4 Quenching efficiency 
Fluorescence of molecular beacons emitted by the closed probe (i.e. no 
target added) was compared to the intensity measured when the 
molecular beacon was assumed to be fully opened (with five-fold molar 
excess of complementary oligonucleotide target). The formula used to 
evaluate quenching efficiency, Q, is as follows: 











Where   
Iprobe = Intensity of molecular aptamer beacon at 0.5 µM without target 
Iblank = Intensity of blank buffer solution  
Itarget = Intensity of molecular beacon + five-fold molar excess of 
complementary target DNA 
 
3.2.5 HeLa cell culture 
Cell lines used in these studies were grown in DMEM supplemented with 
10 % (v/v) FBS, 100 U/ml penicillin and 100 µg/ml streptomycin at 37 °C in 
a 5 % CO2 atmosphere to near confluence. Prior to transfection, cells were 
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transferred onto glass chamber slides and grown in the incubator 
overnight under similar conditions previously described to ensure 
adhesion to the culture dish. 
 
3.2.6 Fixed cell imaging of normal expression of MRCKα  
HeLa cells were fixed onto cover slips with 1000 µl of 4 % (v/v) PFA in 
PBS for 20 min at room temperature and washed with 1 × PBS for 10 min. 
For permeabilization, the cells were incubated in 1000 µl of 0.2 % Triton 
X-100 in PBS for 10 min at 25°C. The cells were then stained with anti-
MRCKα primary antibody at 1:200 dilution in 0.5 % Triton X-100 in PBS 
overnight at 4°C; after washing twice with 1 ml 0.1 % Triton X-100 in PBS 
for 10 min, the cells were incubated for 1 h at 25°C in the dark with Cy3-
conjugated secondary antibody (mouse) at 1:1000 and DAPI at 1:200 
dilution prepared in 0.5 % Triton X-100 in PBS. The cells were washed 
with 0.1 % Triton X-100 in PBS for 5 min twice before final staining with 1 
µM aptamer with 3 h incubation. Stained cells were mounted in Prolong® 
Gold onto glass slides analyzed with an MRC600 confocal imager adapted 
to a Zeiss Axioplan microscope.  
 
3.2.7 Fixed cell imaging of overexpressed MRCKα and P35A  
HeLa cells overexpressed with MRCKα and P35A were kindly prepared 
and provided by Ms Jesyin Lai (IMCB, Singapore). Cells were fixed onto 
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cover slips with 1000 µl of 4 % (v/v) PFA in PBS for 20 min at room 
temperature and washed with 1 × PBS for 10 min. For permeabilization, 
the cells were incubated in 1000 µl of 0.2 % Triton X-100 in PBS for 10 
min at 25°C. The cells were then stained with anti-HA (12CA5) at 1:200 
dilution with 1 µM aptamer in 0.5 % Triton X-100 in PBS for 2 h at 25°C; 
followed by incubation for 1 h at 25°C in the dark with Cy3-conjugated 
secondary antibody at 1:1000 dilution and 1 µM aptamer prepared in 0.5 
% Triton X-100 in PBS. The cells were washed with 0.1 % Triton X-100 in 
PBS for 5 min thrice between each step. Stained cells were mounted in 
Prolong® Gold onto glass slides and analyzed with an MRC600 confocal 
imager adapted to a Zeiss Axioplan microscope.  
 
3.3 Results and Discussion 
3.3.1 MRCKα-binding aptamer beacon design 
DNA aptamers for MRCKα protein were selected by our group using non-
SELEX developed by Krylov et al. [20, 33], which is a modified SELEX 
technique employing capillary electrophoresis as an instrumental platform. 
A representative MRCKα aptamer with a Kd of 125 ± 60 nM was used in 
this work for the design of molecular aptamer beacon. The secondary 
structure of the aptamer as seen in Figure 3.3a was predicted using the 
mFold program under the conditions (50 mM tris, 50 mM NaCl, 5 mM 
MgCl2) at which it was selected.  
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Figure 3.3 Secondary structure of (a) MRCKα aptamer and (b) MRCKα 
molecular aptamer beacon predicted using mFold program under 
selection conditions of 50 mM tris, 50 mM NaCl, 5 mM MgCl2 
 
Hence, we constructed a MRCKα-binding aptamer beacon by adding a 
half stem sequence (i.e. six additional bases CCTACT on the 5’ end, 
which are complementary to the 3’ end) to the MRCKα aptamer so as to 
destroy the existing structure and change it into an MB form. Prior CE-LIF 
studies found that the modification did not affect the binding affinity of the 
aptamer, with the dissociation constant determined to be within the same 
range. The 5’ and 3’ ends are then coupled to commonly used 
fluorophore-quencher pair, i.e. FAM fluorophore and a dark quencher 
DABCYL that quenches fluorescence through contact quenching. The 
secondary structure of the MRCKα M6MAB is as shown in Figure 3.3b. To 
prove that MRCKα M6MAB indeed takes on a hairpin structure, a 
(a) (b) 
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complementary M6 sequence was used to verify the increase in 
fluorescence signal upon binding (Figure 3.3). The quenching efficiency 
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Figure 3.4 Fluorescence emission of MRCKα M6MAB as a function of M6 
complementary sequence concentration, incubated in 50 mM tris, 50 mM 
NaCl, 5 mM MgCl2 
 
The calculated change in Gibbs free energy (∆G) and melting temperature 
(Tm) are -5.6 kcal/mole and 52.2 °C respectively. Both ∆G and Tm were 
used to qualitatively assess the tendency for formation of secondary 
structure and duplex formations under given experimental conditions. ∆G 
measures the stickiness that represents how thermodynamically stable the 
structure may be. At a given temperature, a positive ∆G value indicates 
that the system will go in the direction of producing the reactants (non-
spontaneous), favouring single strandedness for oligonucleotides. A 
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negative value indicates that the system will go in the direction of 
producing the product (spontaneous), favouring double strandedness. Tm 
represents a system in equilibrium where 50 % of the molecular 
population is in one state and 50 % of the population is in the other state. 
In comparison to the MRCKα M6 aptamer, where ∆G and Tm are -2.41 
kcal/mole and 47.8 °C respectively, the MRCKα M6MAB forms the hairpin 
loop more favourably with the addition of a half stem sequence. In the 
presence of MRCKα, however, the equilibrium is shifted towards the 
formation of the MRCKα-aptamer complex, resulting in the preference for 
the MRCKα-binding conformer, where a fluorescence-quenching pair 
added to the 5’ and 3’ ends would signal any protein-dependent 
conformation change.  
 
Figure 3.5 gives the binding curve of the MRCK M6MAB with varying 
concentrations of kinase-active MRCKα-KD. Lower concentrations of 
kinase-active MRCKα-KD in nanomolar range could not be measured as 
the background fluorescence of the M6MAB obscured any changes in 
fluorescence when the ratio of M6MAB to kinase-active MRCKα-KD was 
significantly higher. For example, when 0.5 µM of M6MAB was incubated 
with 5 nM of kinase-active MRCKα-KD, M6MAB binds to the protein to 
form an open structure that causes the fluorophore and quencher to be 
forced apart, giving rise to an increase in fluorescence. However, this 
increase in fluorescence was not sufficiently more than the background 
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fluorescence resulting from inefficient quenching of the closed hairpin 
structure. Therefore, the detection limit of MRCKα-KD was found to be 0.5 
µM. When lower concentration such as 5 nM of M6MAB was used instead, 
the fluorescence signal could not be detected by the microplate reader. 
Hence, a concentration of 0.5 µM of M6MAB, which was within the range 
of molecular beacons typically used in cellular studies as described in 
various publications [180-182], was used. Although other fluorophore-
quencher pairs may be used to reduce the background signal, these 
investigations were considered beyond the scope of the present study 
since our main objective was to determine if the molecular beacon for 
MRCKα based on the hairpin structure design could exhibit fluorescence 
upon binding to the targeted protein in vitro.  
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Figure 3.5 Fluorescence emission of MRCKα M6MAB as a function of 
kinase-active MRCKα-KD concentration, incubated in 50 mM tris, 50 mM 
NaCl, 5 mM MgCl2   
 
A response of approximately 2.3 fold increase in fluorescence at 
saturating kinase-active MRCKα-KD concentrations was observed in 
Figure 3.5. This is comparable to the reported work by Hamaguchi and co-
workers [165] who obtained an approximate of 2.8 fold increase in 
fluorescence for thrombin aptamer beacon. The trend observed suggests 
that the hairpin structure can be used for MAB design, as the response 
with the concentration is quantifiable. However, the relative increase in 
fluorescence was significantly greater when a complementary M6 
sequence was used. This suggested that upon binding of M6MAB to 
active MRCKα-KD, the change in distance between the quencher and 
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fluorophore from the hairpin structure to the bound MAB form was not as 
pronounced as that when a complementary strand was used. Hence, 
more MRCKα aptamer sequences need to be tested as it is expected that 
different sequences would adopt different conformation upon target 
binding, resulting in varying enhancement in fluorescence intensity. A 
larger magnitude change is necessary to achieve higher sensitivity for 
MRCKα for more practical purpose in cellular imaging as the concentration 
of MRCKα in the cell is in the low nanomolar range.  
 
3.3.2 Selectivity studies of MRCKα molecular aptamer beacon 
The specificity of the MRCKα M6 aptamer was previously studied by our 
group using CE. However, there is a need to ensure that modification on 
the aptamer into a MAB does not affect its binding specificity for MRCKα. 
Negative controls were carried out as shown in Figure 3.6.  








0.00 0.50 1.00 1.50 2.00 2.50 3.00
Concentration of target / µM
R
FU
M6MAB + active MRCKα-KD
M6MAB + inactive MRCKα-KD
MisM6MAB + active MRCKα-KD
M6MAB + active PAK1
 
Figure 3.6 Fluorescence emission of MRCKα M6MAB as a function of 
target concentration. Negative controls using inactive MRCKα-KD, active 
PAK1 and mismatched MAB (MisM6MAB) were plotted. Triplicates were 
done for each data point.   
 
When the structurally similar kinase dead mutant or another kinase active 
PAK1 was incubated with the MRCKα M6MAB, fluorescence change was 
reduced. Structurally, kinase-active MRCKα-KD proteins adopt dimeric 
form in which the dimerization is mediated by their N termini. Following 
dimerization, transautophosphorylation takes place and the kinase is 
activated subsequently.  Active MRCKα-KD acts as Cdc42 downstream 
effector and conveys its function in cytoskeleton reorganization upon 
binding to Cdc42. In contrast to active MRCKα-KD, though it is not 
defective in Cdc42 binding, kinase-dead mutant MRCKα-KD is unable to 
form dimer and thus does not undergo transautophosphorylation. The 
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ability to differentiate the active form from the kinase-inactive MRCKα-KD 
indicates the selectivity of the MRCK M6MAB; unlike anti-MRCKα 
antibodies that have the capacity to recognize common epitope of active 
and inactive MRCKα but not the structural difference of active and inactive 
MRCKα kinase domain. Moreover, PAK1 was used to test the cross-
binding effect of M6MAB due to its similarity in kinase domain with 
MRCKα. Both PAK and MRCK belong to the same class of Rho-
associated serine/threonine kinase, therefore there is a need to ensure 
that M6MAB does not interact with PAK1 kinase domain unspecifically. As 
for PAK1, inactive PAK1 is dimerized in head-to-tail fashion whereas 
active PAK1 is autophosphrylated and adopts monomeric structure. 
 
A similar trend was observed when a mismatched MAB (MisM6MAB) was 
incubated with kinase-active MRCKα-KD. MisM6MAB was designed by 
randomly changing three consecutive bases within the aptamer sequence. 
This shows the high specificity of the aptamer sequence to the binding 
sites on the kinase-active MRCKα-KD, and also proves that addition of the 
half stem sequence did not alter the binding properties of the aptamer. 
Nonetheless, further confirmation on the conformational change based on 
NMR and X-ray crystallographic studies is necessary to facilitate probe 
design.  
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The MAB thus has the potential to be employed for the detection of the 
enzyme in situ in its active state but more work needs to be done for 
greater differentiation. The hairpin design for MAB can be easily applied 
for the development of diagnostic assays that generate a change in 
fluorescence upon target binding. To reduce false positives as a result of 
nuclease degradation of nucleic acid probes, a FRET pair with fluorescent 
quencher can be used instead to give a decrease in fluorescence in the 
presence of the protein target. 
 
However, it is far more complicated in the cellular environment, which 
poses a greater challenge for the application of MAB in cellular imaging. 
Previous works on platelet-derived growth factor and thrombin by Vicens 
et al. [162] and O’Sullivan et al. [73, 178] respectively have established 
that MABs remain robust under various biological conditions in terms of 
pH, temperature and salt concentrations. However, these studies were 
done in vitro and thus the aptamer probe needs to be tested under the 
cellular environment. Recall also that the MRCKα aptamer was selected 
only for the kinase domain, therefore it was essential to verify if the 
MRCKα aptamer could recognize the whole protein within the cell. 
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3.3.3 Detection of MRCKα localization in cells using fluorescently 
labeled aptamer 
The normal expression of MRCKα in HeLa cells was first imaged using a 
monoclonal anti-MRCKα antibody. Figure 3.7 shows that endogenous 
MRCKα mainly localizes at two specific networks, in the lamella and cell 
centre. As the expression of MRCKα is rather low, the incubation of the 
anti-MRCKα antibody needs to be done overnight to ensure observation of 
the localization during fixed cell imaging. Besides the long incubation time, 
anti-MRCKα antibody is costly. Hence, it is imperative to exploit aptamers 
as an alternative means for protein detection. Aptamers that can bind 
rapidly to the target will significantly shorten the preparation time. From 
our previous CE results, the aptamers selected for MRCKα-KD displayed 
binding within 15 min. Compared to antibody staining protocols, staining 
with a fluorescently labeled aptamer is potentially more efficient and 
convenient as it does not require long incubation times with a primary 
antibody, and subsequently a secondary antibody. Besides, the cost to 
synthesize a fluorescently labeled MRCKα aptamer is definitely less than 
the antibodies.   
 
One of the limitations in the use of aptamers as recognition elements is 
their nuclease sensitivity which is very critical for their use in ex vivo and in 
vivo applications [183]. Oligodeoxynucleotides containing phosphodiester 
linkages delivered to cells are prone to intracellular degradation, and their 
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half-lives around 20 min [184]. During live cell imaging, ongoing nuclease 
degradation of aptamers gives rise to false signals; therefore fixed cell 
imaging was employed for this work instead. Next, efficient delivery of 
aptamers into the cells is also important to obtain meaningful cellular 
images. Various methods such as microinjection [25, 99-105], streptolysin 
O [106, 107], liposomes [184] and chemical reagents (Lipofectamine [151], 
TransFast [185]) have been applied, each having its own pros and cons 
[31]. However, these methods require the introduction of aptamers into 
live cell before fixation, thus subjecting the aptamers to nuclease 
degradation faced in live cell imaging. Various chemical modifications 
have been published to overcome this problem. However, for the purpose 
of this work, no modification of the aptamer was done for preliminary 
binding studies as modifications may affect the specificity of the aptamer. 
In order to minimize nuclease degradation, cell fixation was first done to 
reduce the activity of the nucleases before permeabilization and 
incubation of the cells with fluorescently labeled aptamers to enable 
staining [181]. For the staining protocol, there was a need to optimize the 
concentration of aptamers used and the incubation duration and 
temperature.  
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Figure 3.7 Fixed cell imaging of normal expression of MRCKα in HeLa 
cells. Cells were permeabilized and stained with (a) FAM-M6 aptamer or 
(b) non-specific oligonucleotide (negative control). The blue fluorescence 
in the merged diagram indicates the nucleus, stained using DAPI. 
 
To ensure that the MRCKα aptamer binds specifically to MRCKα in the 
cells, anti-MRCKα primary antibody with Cy3-conjugated secondary 
antibody was used concurrently during staining. An overlap of 
fluorescence signals resulting from the aptamer and the antibody would 
indicate specific binding of the aptamer. Unfortunately, Figure 3.7 shows 
that MRCKα in HeLa cells was not detectable by the aptamer regardless 
of the concentration or incubation time. When the aptamer was incubated 
with the cells for an hour, the aptamers remained in the cytoplasm with no 
observable binding, thus was postulated that more time was necessary for 
binding. However, the aptamers would go into nucleus with longer 
incubation time. Hence, the results suggest that either the MRCKα 
aptamer was not able to bind specifically to MRCKα within the cells or the 
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expression was too low and the aptamer binding was not strong enough 
for the observation of any localization.  
 
For further verification, MRCKα was overexpressed in HeLa cells (even 
though this leads to perturbation of MRCKα localization at normal 
expression and cell contraction) to study if the aptamer could detect 
MRCKα at higher expressions. Based on the cellular images in Figure 3.8, 
it proved that the MRCKα aptamer bound specifically to MRCKα although 
the fluorescent signal was weak due to the poor contrast. The negative 
controls reinforced this conclusion. The MRCKα aptamer showed no 
binding to P35A overexpressed in HeLa cells; while the control 
oligonucleotide showed non-specific binding to any proteins within the 
cells.  These results further proved that selection of aptamers for only the 
catalytic domain of MRCKα was feasible for the recognition of the whole 
protein. However, it might be necessary to further improve the selection 
procedure to obtain aptamers with Kd in the low nanomolar to picomolar 
range, so that they bind more strongly to MRCKα and do not dissociate 
readily to enter the nucleus. 
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Figure 3.8 Fixed cell imaging of overexpression of MRCKα and P35A 
(negative control) in HeLa cells. Cells were permeabilized and stained with 
(a)-(b) FAM-M6 aptamer and (c)-(d) non-specific oligonucleotide (negative 
control) 
 
One of the expected problems that arose from the cell studies was nuclear 
sequestration. The low molecular weight of aptamers of approximately 10 
kDa allowed it to enter the nuclear pore readily, resulting in a high 
fluorescent signal within the nucleus. As the MRCKα aptamer was 
unmodified, various procedures to tackle this problem such as using 
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HEPES/PIPES buffer, addition of sperm DNA and pretreatment with 
RNase A were attempted as previously reported [92, 186], but there was 
no significant improvements (data not shown). Having proved the 
specificity of the MRCKα aptamer, it is necessary to further investigate on 
aptamer modification methods that do not affect its binding specificity but 
able to prevent both nuclear sequestration and nuclease degradation, so 
that the aptamer can stay in the cytoplasm long enough for target binding 
and subsequently imaging.  
 
3.4 Summary 
The MAB design developed for thrombin aptamer was successfully 
adopted for the MRCKα aptamer, which suggests the possibility to apply 
such a design to other aptamers for probe development. The simplicity in 
design also makes it suitable for diagnostic assays. However, there are 
still many issues to be addressed for the development of aptamer probes 
for the detection of proteins within cells as it is still in its infancy. 
Preliminary studies have proved that the selected MRCKα aptamer 
maintained its specificity for MRCKα even in a more complex cellular 
environment. Hence, it propagates the application of aptamers for protein 
recognition in cellular imaging. Nonetheless, the Kd of the aptamer needs 
to be low enough for strong binding to prevent dissociation and entry into 
the nucleus. This is especially so when the protein expression is low. The 
binding should also not be irreversible such that it cannot be removed by 
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the biological system. Next it needs to be chemically modified for nuclease 
resistance and to prevent nuclear sequestration so that the aptamer has 
ample time for binding to the protein target in the cytoplasm. Various 
chemical modification methods are described in Chapter 4. Since 
aptamers are similar to antibodies such that unbound aptamers/antibodies 
give rise to background signal, therefore the signal-to-background ratio 
must be high enough to observe protein localization. Ideally, MABs with 
hairpin configuration as described can be used during cellular imaging, as 
the background fluorescence would be quenched by the quencher on the 
unbound MABs, but it is not so straightforward. More studies are required 
to ensure that the MABs maintain its configuration in the cellular 
environment. The potential for aptamers or MABs to replace GFP and 
antibodies for fixed and live cell imaging will simplify bench procedures for 
cellular studies as well as reduce the research costs.  
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Chapter 4 Conclusion and Future Work 
The development of aptamers from the improvement in selection 
technologies to its potential applications in diagnostics was explored. A 
newly developed method termed non-SELEX, which employs CE as an 
instrumental platform, was used for the selection of aptamers with high 
affinity for the signal transduction proteins Cdc42-GTP, PAK and MRCK. 
Many unique sequences with Kd in the low micromolar to nanomolar range 
were identified for each protein, thus reinforcing the applicability of the 
reported method to any proteins of interest regardless of difference in 
physical properties. These aptamers can then be utilized as analytical, 
diagnostic and therapeutic reagents. The ease to modify selection 
conditions for adjustment of binding parameters of aptamers makes non-
SELEX highly efficient; and the possibility of automation based on CE 
instrumentation, renders non-SELEX a useful tool for commercialization.   
 
The potential application of aptamers in cellular imaging to replace current 
technologies using GFP and antibodies was also studied. It was 
concluded that the MRCKα aptamer maintained its specificity for MRCKα 
even in a complex cellular environment. Further, the aptamer selected for 
only the catalytic domain could recognize the whole MRCKα protein within 
the cells. Hence, it was also proven that the aptamers bound specifically 
to the recognition site and that selection of aptamers can be done for a 
particular domain of a protein if the whole protein cannot be prepared.   
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Nonetheless, the application of aptamers in complex biological matrix 
requires chemical modification to enhance nuclease stability and if used in 
cells, to also prevent nuclear sequestration. To overcome nuclease 
degradation, backbone modification of the aptamers is necessary. It has 
been shown that the stability of oligonucleotides can be improved by 
chemical modification of the ribose ring at the 2’-position [187]. The most 
abundant nucleases in biological fluids are the pyrimidine-specific 
nucleases, thus introduction of specific modifications at the 2’-position of 
pyrimidine nucleotides (2’-amino and 2’-fluoro functional groups) protects 
an RNA oligonucleotide from degradation [188]. Incorporation of 2’-amino 
and 2’-fluoro CTP and UTP into in vitro transcribed RNA can also be 
introduced into the combinatorial library during SELEX. Conversely, 2’-O-
methyl RNA backbones is a common post-transcriptional modification and 
relatively less expensive to synthesize. Studies have found that 2’-O-
methyl RNA do have enhanced stability compared with ssDNA but their 
target specificity is slightly reduced. Other modifications include 
boranophosphate or phosphorothioate internucleotide linkages, 5-modified 
pyrimidines and 4’-thio pyrimidines [46, 189-191]. However, Tan et al. 
claimed that DNA analogues meet with problems, such as toxicity, self-
aggregation, or nonspecific binding by DNA/RNA-binding proteins and 
overcame the problem with the use of locked nucleic acid (LNA) bases 
[192] that demonstrated extremely high biostability. LNAs are a class of 
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nucleic acid analogues in which the ribose ring is “locked” by a methylene 
bridge connecting the 2’-O atom and the 4’-C atom. For efficient 
enrichment of these modified nucleic acid libraries during the SELEX 
procedure, further development into new polymerases is required. It is 
also important to note that these backbone modification methods may be 
useful only for aptamers targeting cell surface proteins and not within the 
cells as nuclear sequestration may still be an issue. 
 
A significant problem during cellular imaging of protein localization is the 
entry of aptamers into the nucleus. Stanlis and McIntosh reported various 
blocking and treatment methods to reduce non-specific background 
staining [186]. However, the proposed protocol does not entirely overcome 
the problem and might not be able to produce consistent results to be 
employed as a universal procedure. It is thus more favourable to 
chemically modify the aptamer to prevent nuclear sequestration. Chen et 
al. [193] indicated that 2’-O-methyl RNA backbones elicit a nonspecific 
signal in the nucleus and have proposed the conjugation of molecular 
beacons to NeutrAvidins delivered using microporation, which reduced 
false-positive signals to marginal levels. The presence of bulky proteins 
attached to molecular beacons stopped their entry into the nucleus 
through the nuclear pores. Dougan et al. patented their work using a 
similar biotin-streptavidin bioconjugates of the thrombin aptamers to 
extend aptamer lifetime rather than to prevent nuclear sequestration for 
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thrombus imaging [194]. This proved that aptamers could be modified in a 
similar fashion as molecular beacons but more research is required for its 
effect on binding specificity within cells. Another solution described is 
tRNA-linked molecular beacons. Mhlanga et al. [195, 196] overcame 
nuclear sequestration of molecular beacons by attaching them to in vitro-
transcribed tRNAs. The presence of tRNAs increased the residence time 
of the molecular beacons in the cytoplasm and enabled them to bind 
specifically to target mRNAs, signaling the presence of their targets. The 
advantage of using tRNA transcripts offered a simple means of 
attachment via engineered cohesive ends. Despite the improvement in 
cellular images obtained for DNA or mRNA detection using molecular 
beacons, these conjugation methods have yet been exploited for 
aptamers used for protein recognition within cells. In view of the potential 
challenges, there is a need to establish a foolproof method for the 
development of aptamer with high biostability to overcome both nuclease 
degradation and nuclear sequestration without the compromise of its 
specificity. 
 
Since unbound aptamers in cells give rise to background signal, it is 
imperative to propose the development of MABs with hairpin configuration 
for cellular imaging, as the background fluorescence would be quenched 
by the quencher on the unbound MABs. However, there is a need to 
ensure that the MABs maintain its configuration in the cellular environment 
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as this thesis only looked into its behaviour in solutions. The MAB also 
needs be sensitive enough to give a significant fluorescence enhancement 
for low expression of proteins.  
 
With the conjugation of aptamers/MABs with near-infrared (NIR) 
fluorophores, gold nanoparticles or quantum dots, there is great potential 
for its use to monitor the biological activity of a wide variety of molecular 
targets such as intracellular enzymes, cell surface receptors, and antigens, 
as well as other targets, providing a unique opportunity to achieve insight 
into the biological events involved with these molecules of interest. NIR 
optical imaging technology is a highly sensitive imaging modality, which 
does not require use of ionizing radiation or radioactive materials and is 
emerging as a powerful technology for studying diseases at molecular 
level in small animal models. In fact, recent simulations have 
demonstrated that NIR fluorescence may be able to penetrate over a 
distance of 10 centimetres, making it a plausible detection technique for 
use in human subjects [197]. Water and biological tissues have minimal 
absorbance and autofluorescence in the NIR window (650-900 nm), thus 
allowing efficient photon penetration into, and out of tissue with low intra-
tissue scattering. Hence, it is of interest to work towards the development 
of NIR MAB probes, as this will make a significant impact in disease 
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